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ABSTRACT 
Cancer cells often display a dependence toward the amino acid L-glutamine for their 
survival, a phenomenon termed glutamine addiction. The mouse hybridoma Sp2/0-Ag14 (Sp2/0) 
undergoes rapid apoptotic cell death upon glutamine deprivation, making it a useful model for 
uncovering the molecular and cellular processes through which glutamine controls cell survival. 
This work was aimed at gaining a better understanding of the molecular and cellular events 
triggered when Sp2/0 cells are exposed to limiting amounts of glutamine.  
First, the effect of glutamine limitation on Sp2/0 cell behavior was investigated. We 
found that a threshold concentration of 100 µM glutamine exists where Sp2/0 cell density does 
not increase, but cells remain viable. Under this threshold, Sp2/0 cells underwent apoptosis, but 
in a more protracted fashion than under conditions of acute glutamine deprivation.  
Unexpectedly, I found that exposure of Sp2/0 cells to 25µM glutamine triggered a biphasic 
activation of caspase-3. Interestingly, glutamine limitation, but not acute glutamine deprivation, 
was sufficient to maintain intact mitochondria for several hours and to trigger the expression of 
the stress-related transcription factor GADD-153. My results raise the possibility that glutamine 
limitation triggers a stress response which could enable Sp2/0 cells to adapt to its environment. 
Using microscopic and biochemical techniques, I also provided evidence for a reduction 
in autophagic processes in Sp2/0 cells exposed to glutamine-limiting conditions. Chemical 
inhibitors of autophagy caused Sp2/0 cell death even in the presence of adequate supply of 
glutamine. On the other hand, rapamycin, a known activator of autophagy, improved Sp2/0 
viability under glutamine limitation conditions. Therefore, the loss of Sp2/0 cell viability when 
!iv 
exposed to limiting amounts of glutamine could be the result, at least in part, of a reduction in the 
cell’s autophagic capabilities.  
Finally, I explored the effect of ammonium ions, a product of glutamine metabolism, on 
the behavior of Sp2/0 cells exposed to limiting amounts of glutamine. Ammonium ions treatment 
rescued Sp2/0 cell viability and proliferation in Sp2/0 cells cultured in glutamine-limiting 
conditions. Interestingly, ammonium acetate, but not ammonium chloride, caused a reduction in 
caspase-3 activity in Sp2/0 cells maintained under limiting glutamine conditions. Finally, my 
data suggest that ammonium salts led to a partial restoration of the autophagy process in Sp2/0 
cells exposed to limiting amounts of glutamine, providing a potential explanation for the 
beneficial effect of ammonium ions on cell viability. 
All together, the results obtained in the course my studies argue in favor of a mechanistic 
link between autophagy and ammonium ions in the modulation of the viability of a Sp2/0 cells 
exposed to glutamine-limiting conditions. 
Keywords 
Macroautophagy, autophagy, apoptosis, glutamine, cell signalling, survival, adaptation, 
molecular biology, ammonium. 
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1.0 — INTRODUCTION 
1.1 — The Warburg Effect and Metabolic Reprogramming 
In 1927, Otto Heinrich Warburg published "The metabolism of Tumors in the Body" 
describing the use of glucose fermentation to produce energy in cancer cells when compared to 
normal cells (1). The fermentation reaction was described as the formation of lactate from 
glucose in the presence of oxygen, a process we now call aerobic glycolysis. In 1956, his "On the 
Origins of Cancers" in the journal Science proposed that the underlying cause of cancers was 
defects in respiration and the increase in glucose fermentation which has since been dubbed the 
Warburg effect (2).  
The Warburg effect can be defined as a preferential use of glycolysis to produce 
adenosine 5'-triphosphate (ATP) over oxidative phosphorylation, even under aerobic conditions. 
This increase in glycolysis is accompanied by higher glucose uptake, a high lactate production 
and a suppression of respiration (3). Warburg attributed impaired respiration to defective 
mitochondria. Contrary to the Warburg's speculations that cancer arose from a decrease or defect 
in mitochondrial metabolism, some cancers have normal or even increased mitochondrial 
function (4-6). Recent studies indicate that inactivating mutations in mitochondrial DNA or in 
Krebs cycle enzymes (encoded by the nuclear genome) could be in part responsible for the effect 
described by Warburg (7). One of the main reasons to increase glucose uptake in tumour genesis 
is its ability to generate biosynthetic precursors through glycolysis and the pentose phosphate 
shunt. 
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1.2 — Generation of Biosynthetic Precursors from Glucose 
In resting differentiated cells, glucose metabolism is shuttled through the glycolytic 
pathway to produce 2 molecules of pyruvate per molecule of glucose in the cytoplasm. The 
produced pyruvate enters mitochondria and is shuttled through the tricarboxylic acid (TCA) 
cycle and oxidative phosphorylation to produce ATP, H2O and CO2 molecules. The cellular 
business of proliferation requires the duplication of the entire cellular contents, and glucose 
metabolism shifts accordingly. In these conditions, most of the pyruvate is kept in the cytosol 
and converted to lactate by the activity of lactate dehydrogenase (allowing the formation of 
NAD+, which is essential to glycolysis), while a limited amount of pyruvate is converted to 
acetyl CoA and shuttled into the TCA to produce citrate, enabling its use in fatty acid synthesis 
in the cytosol (4, 8). 
The produced lactate can be excreted from the cell, transported to the liver or kidneys 
where it can be reconverted into glucose, to the heart and skeletal muscle to be used as an 
oxidative metabolite, or be reconverted to pyruvate by vascular endothelial cells (9, 10). In 
proliferating cells, the production of lactate is essential. Interestingly, a study of the effects of 
lactate on cytotoxic T lymphocyte function reported that lactate in culture media could suppress 
proliferation and cytokine production by up to 95%, and decrease cytotoxic activity by 50%. 
This outcome would be desirable for tumour proliferation (11). Additionally, it was reported that 
lactate is used by glucose-deprived cancer cells as fuel and contributed to tumour angiogenesis 
by promoting the activation of the nuclear factor κB (NF-kB) pathway (12). 
When a growth factor binds to its cognate tyrosine kinase receptor, it activates the PI3K-
AKT pathway. This activation leads to an increase in glucose uptake by stimulation of glucose 
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transporters, stimulation of hexokinase to produce more glucose-6-phosphate, and stimulates 
phosphofructokinase to produce more glyceraldehyde-3-phosphate. Moreover, tyrosine kinase 
phosphorylation of pyruvate kinase inhibits this enzyme, preventing progression through the 
mitochondrial steps of glucose metabolism, and allows for the channelling of glucose 
metabolites into other pathways (see figure 1.1) (4, 13). 
During anaerobic glycolysis, glucose metabolites are channelled to the pentose phosphate 
pathway in order to produce ribose-5-phosphate, a crucial precursor for nucleotide synthesis. In 
the oxidative arm of the pathway, 2 molecules of NADP+ are reduced to NADPH, which 
provides the cell with the reductive potential essential for biosynthetic reactions. Ribose-5-
phosphate is produced through the non-oxidative arm by combination of glyceraldehyde-3-
phosphate, a glycolysis metabolite, to fructose-6-phosphate. Alternatively, fructose-6-phosphate 
is shuttled into the hexosamine pathway in order to produce UDP-N-acetylglucosamine, which is 
used to modify proteins by N-linked and O-linked glycosylation, allowing for proper folding of 
peptides (13-15).  
In a study of several interleukin-3-dependent hematopoietic cell types, glucose 
deprivation led to a downregulation of growth factor receptor expression, decreased glutamine 
uptake, a depletion of TCA and cellular atrophy. The observed downregulation was reversed by 
restoration of the hexosamine biosynthetic pathway through addition of N-acetylglucosamine 
(GlcNAc), which permitted proper receptor folding, resulting in increased glutamine 
consumption and restored mitochondrial function (15).  
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Figure 1.1 - Glucose Metabolism to Generate Metabolic Precursors 
Glucose can be used to generate biosynthetic precursors and energy. In 
proliferating cells, glucose metabolites are diverted from glycolysis to the pentose 
phosphate pathway to generate ribose-5-phosphate, a critical molecule in the 
synthesis of nucleotides. Alternatively, glucose metabolites can be diverted to the 
hexosamine pathway which provides glycosylation molecules for post-
translational modifications of proteins. The proliferative signals transduced 
(yellow box) are represented to indicate where their influence is directed in the 
glycolytic pathway. Enzymes appear in purple. A red arrow indicates an 
inhibitory effect while a green arrow indicates stimulation. Blue boxes indicate 
the metabolic pathway. Metabolites that are used in different metabolic pathways 
of glucose are represented in bold type. P: phosphate, GFAT: glutamine-fructose-
6-phosphate aminotransferase, GT: glucosamine-6-phosphate N-acetyltransferase, 
PT: phosphoacetlyglucosamine mutase, UDP: UDP-N-acetylglucosamine 
pyrophosphorylase.1 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
1 Figure 1.1 adapted from Vander Heiden et al (4) 
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Over the last few decades, many reports have described the metabolic reprogramming 
responsible for the increase in the rate of conversion of glucose to lactate. Ras and Src cellular 
transformation are both associated with increases in glucose uptake, direct activation of lactose 
dehydrogenase A (LDHA), AKT-dependent increases in glucose uptake via the mobilization to 
the plasma membrane of glucose transporter and activation of hexokinase-2 to trap intracellular 
glucose (5, 16-21). The p53 tumour suppressor transactivates the SCO2 gene to allow the 
formation of the cytochrome c oxidase complex, a necessary component of oxidative 
phosphorylation. If either p53 or SCO2 function is lost, as observed in many tumour types, the 
cell is reprogrammed to use aerobic glycolysis (22).  
While glycolytic metabolites are being diverted away from the TCA, there is another 
substrate that can also be used to fuel proliferation and provide macromolecule building blocks: 
glutamine. 
1.3 — Glutamine 
Glutamine is one of the 20 standard amino acids used for protein synthesis and has many 
diverse functions in the cell. The intracellular concentration of glutamine varies by cell type and 
ranges from 2 to 20 mM. Its serum concentration in humans averages 0.7 mM. At a neutral pH, it 
is found in its zwitterion form (23). As skeletal muscles can synthesize glutamine, it is not an 
essential amino acid. However, in times of stress, such as illness, surgery and exercise, glutamine 
becomes conditionally essential (24, 25). It has been postulated that the release of glutamine into 
the extracellular space could act as a stress signal, activating signalling pathways necessary for 
cellular protection and immune regulation (26).  
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Glutamine uptake into cells triggers swelling, a process that has been linked to the 
presence of ammonium ions generated during glutaminolysis (discussed below) (27). This may 
be the trigger to regulate some anabolic pathways, such as the synthesis of proteins, of DNA and 
RNA(28). Cell swelling has also been linked to pro-inflammatory cytokines IL-6 and TNF-α 
(29), two cytokines known to be affected by glutamine levels (23, 30-32). In these reports, the 
presence of glutamine decreased the secretion of these cytokines. Conversely, glutamine 
deprivation has been reported to cause cell shrinking, which was followed by apoptosis (33, 34). 
1.4 — Glutamine as an Energy Source 
Glutamine can be used as a source of energy in many different cell types (35, 36). While 
glucose metabolites are being redirected to the synthesis of membranes, nucleotides and amino 
acids, which require more carbon and NADPH than ATP, glutamine can be used to supplement 
the TCA cycle (4) (see figure 1.2).  
Glutamine enters the cell via glutamine transporters and can enter the TCA cycle after 
deamination to glutamate by glutaminase (GLS) before being shuttled into mitochondria, where 
glutamate is converted into α-ketoglutarate (α-KG) by glutamate dehydrogenase. The released 
amine groups are protonated to form ammonium ions (37). Once in the TCA cycle, glutamine (as 
α-KG) can have different metabolic fates. In enterocytes, it is metabolized to L-alanine by its 
conversion to malate which is used by malic enzyme to form pyruvate. The latter is then used in 
transamination reactions to synthesize L-alanine. There are alternatives in other cell types or cell 
states: the produced pyruvate can be converted to lactate and released from mitochondria as 
waste, glutamine can be shuttled into the TCA cycle to produce citrate for lipid synthesis, to 
 7!
produce acetyl-coA for amino acid synthesis or for complete oxidation (23). In the cytosol, 
glutamine can also be used to generate glycosylation molecules through the hexosamine pathway 
(see figure 1.1) (10).  
 
Figure 1.2 - Interplay of Metabolic Pathways in Proliferating Cells  
This schematic illustrates the interplay between glucose and glutamine 
metabolism by depicting their interactions in various cellular pathways necessary 
to proliferating cells including glycolysis, oxidative phosphorylation, the pentose 
phosphate pathway and glutaminolysis as currently understood. The Myc 
oncogene (yellow box) increases the rate of glutaminolysis. Important metabolic 
processes are in blue boxes, and critical enzymes controlling them in purple2.  
Therefore, both glucose and glutamine can be converted into lactate and used to generate 
biosynthetic precursors. A recent report showed that the glutamine consumed by proliferating 
cells was metabolized and accounted for as much 90% of the lactate and 60% of the alanine 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
2 Figure 1.2 adapted from Vander Heiden et al (4). 
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produced (38). This research group reported that glutamine metabolism alone was sufficient to 
fulfill the metabolic requirements for NADPH for fatty acid synthesis and to sustain the levels of 
oxaloacetate needed to fuel the TCA cycle. They also concluded that since ammonium ions and 
alanine, along with lactate, were secreted from the cell as waste, the rate of glutamine catabolism 
was not driven solely by the need to synthesize nucleotides or amino acids. Rather, glutamine 
metabolism was used as a carbon source (38). It must be considered that cells that are producing 
lactate and excreting it stimulate the expression of CD44 and the production of its 
glycosaminoglycan ligand, hyaluronan. Upon ligand binding to CD44, cells decrease their 
attachment to the extracellular matrix, allowing them to move (39). Also, the excretion of lactate 
to the extracellular matrix suppresses cytotoxic T cell proliferation and cytokine production and 
is therefore immune suppressive (11, 40). 
1.5 — Glutamine in Proliferating Cells 
The importance of L-glutamine in the process of cell proliferation has been known since 
Harry Eagle's seminal work was published in 1955 in the journal Science (41). Glutamine intake 
is high in cells with a high rate of division such as enterocytes, lymphocytes in clonal expansion 
and some types of tumour cells (42-46). Glutamine has also been shown to activate protein 
kinase A (PKA) and mammalian target of rapamycin (mTOR), two kinases that are important in 
cell proliferation (47). mTOR, when combined with Raptor and mLST8, form the mammalian 
target of rapamycin complex 1 (mTORC1); this complex controls cells growth and the uptake of 
nutrients. The activation of mTORC1 is a molecular switch, turning on anabolic processes like 
glucose uptake, glycolysis, the pentose phosphate pathway and de novo synthesis of lipids, while 
 9!
turning off catabolic processes, including autophagy. A deregulation in mTORC1 activation is 
frequently observed in cancer and would result in the observed Warburg effect (48).  
Glutamine is utilized as a precursor for the synthesis of molecules such as proteins, 
nucleic acids, amino sugars, and GSH (23, 28). In one study, the supplementation of Caco-2 cells 
with glutamine but not glutamate stimulated proliferation and nucleotide synthesis. Interestingly, 
these investigators also showed that this effect was not the result of the use of glutamine as an 
energy source (28). Another report specifically followed the metabolism of glutamine in 
proliferation. They also concluded that glutamine was used as a carbon source as ammonia and 
alanine were excreted from the cell as waste; the rate of glutamine catabolism was not driven 
solely by the need to synthesize nucleotides or amino acids (38). When one compares the 
chemical structures of glutamine and glutamate, one can notice that deamination of glutamine 
yields glutamate; therefore, the amine group of glutamine appeared to be critical. 
There is growing evidence that glutamine is a key molecule in several types of tumours, 
many with quite dismal prognoses, and withdrawal of this amino acid induced apoptosis in 
intestinal epithelial, neuronal and lymphoid cells (6, 34, 49-53). One proposed mechanism for 
this glutamine dependence has been linked to the overexpression of the oncogene c-Myc (aka 
Myc) (50, 52, 54).  
Myc expression is associated with the modulation of diverse cellular processes, including 
cell growth, proliferation and energy metabolism, stimulating cell growth while inhibiting the 
arrest of the cell cycle (55). Myc is a transcription factor driving proliferation first discovered in 
Burkitt's lymphoma (56). Activation of Myc in a human B cell model resulted in increased 
mitochondrial respiration and biogenesis, and when Myc activity is sustained at an elevated rate, 
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it is associated with increases in reactive oxygen species (ROS) levels (19, 22, 57, 58). In a 
recent report examining the different gene products expressed between Myc-high and Myc-low 
B cell lines, mitochondrial GLS as well as glutamine transporters were highly expressed in the 
Myc-high B cell line (52, 54, 59). In myeloma cell lines, the myc gene is found to be translocated 
to the immunoglobulin locus, making it highly expressed (60). Myc-driven proliferation has been 
shown to render cells extremely sensitive to the levels of available glutamine, rendering them 
"addicted" to this amino acid. Glutamine withdrawal in Myc-transformed cells has been reported 
to result in rapid cell death (50, 52, 54, 59).  
Recently, it was reported that mTORC1 could stimulate glutamine metabolism by 
repressing mitochondrial sirtuin-4 (SIRT4). SIRT4 represses glutamine metabolism by inhibiting 
the activity of glutamate dehydrogenase by ADP-ribosylation (61). SIRT4 has also been linked 
to the DNA damage response by inhibiting glutamine metabolism, and loss of SIRT4 has been 
linked to tumour development, particularly in tumour types that are reprogrammed to glutamine 
addiction, such as Myc-transformed cells (61-63).   
Proliferating cells need to synthesize lipids to form the plasma membrane. While 
convention holds that acetyl-CoA generated from glucose-produced pyruvate is the primary 
source of carbon for lipid synthesis (64, 65), other reports have shown that glutamine, via α-KG 
and malate, can produce pyruvate to be used for lipogenesis, or that reductive glutamine 
metabolism by isocitrate dehydrogenase-1 can generate the required acetyl-CoA (38, 66-70).  
Glutamine has traditionally been seen as a building block for the production of 
macromolecules or as fuel, but its importance in normal cell function goes beyond these 
narrowly defined roles: the presence of glutamine and its metabolites can signal the cell to alter 
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its behaviour. Conversely, the absence of glutamine can also have profound effects: glutamine's 
absence can trigger cell death.  
1.6 — Glutamine Metabolism Can Modulate Signalling Pathways 
The presence or absence of available glutamine can influence cell behaviour, which will 
vary according to cell type and function (its pro-survival role will be discussed further in a 
separate section). For example, it has been reported that glutamine can stimulate or inhibit 
autophagy depending on the cell type. Interestingly, in co-culture experiments with fibroblasts 
and MCF7 cells, glutamine increased autophagy markers in the fibroblasts, but downregulated 
those same markers in MCF-7 cells while protecting them from apoptosis (71). In a recent report 
on human pancreatic ductal adenocarcinoma (PDAC) cells where KRAS reprogrammed 
metabolism, a non-canonical metabolism of glutamine was described. PDAC tumours are very 
aggressive, resistant to therapy and respond to changes in the levels of glutamine. In PDAC cells, 
13C-labelled glutamine was traced through its metabolism. Interestingly, the majority of aspartate 
(50-75%) was labelled indicating that glutamine was the carbon source. In PDAC cells deprived 
of glutamine, an accumulation of ROS, of GSH disulfide and a concomitant loss of growth were 
observed. α-KG supplementation alone did not rescue growth in PDAC cells deprived of 
glutamine, but a mixture of α-KG and non-essential amino acids derived from glutamine 
metabolism did. Inhibition of either cytoplasmic aspartate transaminase (GOT1) or the 
mitochondrial aspartate transaminase (GOT2) was identified as being critical to glutamine 
metabolism, rather than glutamate dehydrogenase (see figure 1.3). GOT1 catalyzes the 
conversion of aspartate and α-KG into oxaloacetate and glutamine in the cytoplasm. The reverse 
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Figure 1.3 - Non-Canonical Metabolism of Glutamine by KRAS 
Reprogramming 
This figure depicts the reprogramming of glutamine metabolism by KRAS in 
PDAC cells to render them sensitive to glutamine levels. In these aggressive 
tumour cells, glutamine is converted to aspartate in the mitochondrion, exported 
to the cytoplasm and then metabolized to pyruvate to produce redox potential and 
remove reactive oxygen species. KRAS reprogramming stimulates the need for 
aspartate by upregulating the expression of GOT1 and downregulating the 
expression of GLUD1. Enzymes are depicted in purple. GLS1: glutaminase, 
GOT1 cytoplasmic aspartate deaminase 1, GOT2: mitochondrial aspartate 
deaminase 2, GLUD1: glutamate dehydrogenase, MDH1: malate dehydrogenase, 
ME1: malic enzyme, GSH: glutathione, GSSG: glutathione disulfide, OAA: 
oxaloacetate, α-KG: α-ketoglutarate3.  
reaction is catalyzed by GOT2. KRAS reprogramming of glutamine metabolism saw glutamine 
being converted into aspartate, exported to the cytoplasm, reconverted to glutamine and 
metabolized to pyruvate to produce NADPH, thus providing PDAC cells with redox potential to 
deal with ROS via GSH (72). Glutamine also contributes to the redox potential of cells in the 
synthesis of GSH. GSH is a tri-peptide formed from glutamine-derived glutamate, glycine and 
cysteine which is oxidized by hydrogen peroxide to form water and glutathione disulfide (73).  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
3 Figure 1.3 adapted from Son et al (72). 
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Glutamine can also modulate inflammatory responses. NF-κB is a transcription factor 
that is involved in the expression of genes in inflammatory responses and glutamine's anti-
inflammatory effects in intestinal mucosa had been reported to be mediated via this transcription 
factor. In intestinal cells, glutamine has been shown to reduce protein degradation mediated by 
the ubiquitin-proteasome system. Ubiquitin is a small protein that is used to modify proteins after 
translation and can have differential effects, from tagging proteins for degradation by the 
proteasome to modulating intracellular sorting. The outcome of ubiquitylation is dictated by the 
location of ubiquitylation, the length of the ubiquitin chain, and the level of its branching (74). In 
a study of intestinal cell lines, glutamine treatment was associated with a decrease in the 
ubiquitylation  of the inhibitor of NF-κB (IκBα) leading to a decrease in the expression of pro-
inflammatory interleukin-8 in HCT-8 cells without affecting ubiquitin levels or proteasomal 
activity (31). Conversely, glutamine treatment of Caco-2 cells lead to the proteasomal 
degradation of NF-κB via activation of the p38 MAPK (75). In a study performed on biopsies 
taken from human duodenal mucosa, an infusion of glutamine was shown to have affected the 
ubiquitylation  of proteins, among them Grp75, involved in anti-inflammatory responses, and of 
heat shock protein 74, a protein indirectly regulating cell survival and proliferation in periods of 
stress (76).  
Glutamine can provide cells with the ability to respond to stress. Heat shock proteins are 
a group of conserved proteins that are expressed to allow cells to adapt to stress conditions such 
as heat shock. They mediate this adaptation response by aiding in protein refolding and by 
preventing the aggregation of proteins in the cytoplasm. The transcription of key heat shock 
proteins is regulated by heat shock transcription factor-1 (HSF1). Glutamine has been reported to 
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upregulate the expression of HSF1, increase its transactivation and heat shock protein expression 
(77). 
One of two glutaminase isoforms, glutaminase-2 (GLS2), is regulated by p53 in response 
to oxidative stress or DNA damage. In response to DNA damage caused by DNA oxidation, p53 
upregulated the expression of GLS2, to facilitate glutamine metabolism and the synthesis of 
GSH to allow cells to recover from repairable genotoxic stress (78). In neuronal differentiation, 
glutaminase has been shown to play a crucial role in neuronal differentiation. A p53 family 
member, p73, was shown to be essential to GLS2 expression during neuronal differentiation, 
with GLS2 playing a part in the regulation of glutamate synthesis, a crucial neurotransmitter 
(79). This fact is made relevant when one considers reports that glutamine, not glutamate, can 
stimulate proliferation and nucleotide synthesis. That effect does not depend on glutamine being 
used strictly for the generation of energy or nucleotide synthesis, since alanine and ammonia 
were excreted. This indicates that the amine moiety had a specific role (28) and that glutamine 
was used as the main carbon source (38). Additionally, cell death in long-standing glutamine free 
cultures could be rescued with the addition of ammonia by stimulating anabolic pathways and 
that glutamine's amine moiety was required for proliferation of tumour cells, not just as a source 
of carbon (80).  
The enzyme glutamate dehydrogenase, which catalyzes the conversion of glutamate to α-
KG, has been shown to inhibit autophagy by stimulation of mTOR in HeLa cells (81). Leucine, 
which is taken up by cells when glutamine is effluxed, is a most potent stimulator of mTORC1 
and autophagy inhibitor in HeLa, U2OS and MCF-7 cells (82-84). As glutamine is a non-
essential amino acid, its accumulation within the cell acts as a signal that nutrients are plentiful 
and that proliferation can be sustained, signalling the cell to take up essential amino acids such as 
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leucine. The predominant model states that mTORC1 activity in nutrient-rich conditions is 
recruited to the lysosomal membrane where it interacts with Rheb to form a complex with RAG 
GTPases that are activated by the presence of amino acids. This complex allows the activation of 
mTORC1 and prevents the autophagy initiation complex from being formed by phosphorylating 
ULK1 on S757 (83, 85-87). During amino acid starvation, mTORC1 activity is inhibited by 
phosphorylation by several kinases, such as AKT, AMPK, and results in cell cycle arrest in G1 
(86, 88, 89). In the presence of ROS, phosphatase 2A associates with its B55α subunit to activate 
p53 and inhibit mTOR, promoting cell survival and proliferation in low glutamine concentrations 
(90). In rapidly proliferating cells that are increasing their uptake of glutamine from the 
extracellular space (like in Myc-transformed cells), it is possible that glutamine is deaminated 
before it can be effluxed as it would be in nutrient-rich conditions of non-proliferating cells. This 
mTOR-independent pathway may be more important in cell populations that are rapidly 
undergoing proliferation and cannot be solely dependent on de novo synthesis of 
macromolecules. There is evidence for this with the observation that amino acid deprivation 
induced autophagy in an ULK1/2-dependent manner, but that rising levels of ammonia arising 
from increased glutaminolysis in glucose deprivation was ULK1/2 independent (91, 92).  
In illness, such as sepsis or bacterial infections, the administration of glutamine was 
shown to improve clinical outcomes (26, 93, 94). In rat macrophages treated with 
lipopolysaccharide (LPS), a bacterial product known to induce inflammatory responses in septic 
shock, glutamine treatment minimized the inflammatory response by dephosphorylating p38 and 
JNK both in vitro and in vivo. Glutamine elicited this response in a matter of minutes, and 
effected the response in an ERK-dependent activation of MAP kinase phosphatase-1 (95). In rat 
cardiomyocytes treated with LPS, glutamine treatment attenuated LPS-induced LDH 
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upregulation and upregulated the levels of O-linked β-N-acetylglucosamine (O-GlcNAc), a post-
translational modification involved in stress response and signal transduction. Glutamine, 
flowing through the hexosamine pathway (see figure 1.1), provides the amino moiety in the 
formation of glucosamine-6-phosphate, which is then metabolised to UDP-N-acetyl-
glucosamine, the obligatory substrate for O-GlcAc (96). Glutamine treatment increased the 
endonuclear HSF-1 expression and transcription activity, which increases the expression of heat 
shock proteins (77). Furthermore, glutamine induced heat shock protein 70 (HSP70) and 
glutathione (GSH) expression to alleviate damage to cardiomyocytes and preserve cardiac 
function in LPS-treated rats (96-99). The successful clearance of infection requires that an 
inflammatory response be activated and robust. However, sepsis tells us that too much 
inflammation can cause more damage than the initial infection, leading to the death of the patient 
(26, 94). The inflammatory response must be kept in balance to ensure that there is enough 
response to be effective, but not so robust as to cause damage. Glutamine provides that balance 
by activating signalling pathways responsible for the attenuation of the inflammatory response. 
1.7 —Apoptosis and Its Regulation by Glutamine 
1.7.1 — Apoptosis 
Apoptosis is a form of programmed cell death mediated by caspases and characterized by 
the orderly dismantling of the cellular content, cleavage of DNA and formation of apoptotic 
bodies which are cleared by neighbouring cells without triggering inflammatory responses (100). 
Apoptosis can be triggered by signals external to the cell (extrinsic pathway) or by cellular 
signalling from within (intrinsic pathway) (see figure 1.4).  
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Figure 1.4 - The Apoptotic Pathways 
Basic depiction of the apoptotic pathways. On the right is the intrinsic apoptotic 
pathway. Upon receiving a distress signal from within the cell, for example 
GADD-153, pro-apoptotic Bcl-2 family members (BH3, red) are dissociated from 
their anti-apoptotic Bcl-2 family members (Bcl-2, green), and permeabilize the 
mitochondrial outer membrane, allowing factors like cytochrome c (Cyt c, green) 
to escape into the cytoplasm. Cytochrome c associates with pro-caspase-9 
(initiator caspase, yellow) to form the apoptosome. Once activated, the 
apoptosome can cleave and activate effector caspases (caspase 3/6/7, grey) to 
effect the apoptotic phenotype. On the left is the extrinsic apoptotic pathway. This 
pathway is typically triggered by a death ligand (fushia) binding to its cognate 
death receptor (blue), causing receptor clustering and recruitment of adaptor 
proteins (FADD, light blue) and caspase-8 (initiator caspase, orange). Once 
activated, caspase-8 can activate effector caspases and can cleave BID, to initiate 
the intrinsic pathway of apoptosis4.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
4 Figure 1.4 adapted from Franco et al (73). 
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In a brief description of the extrinsic pathway, a death ligand will bind to its cognate 
death receptor and trigger receptor oligomerization, which in turn recruits adapter proteins such 
Fas-associated protein with death domain (FADD).  The adapter proteins in turn recruit the pro-
caspase-8. At this point, the death-inducing signalling complex (DISC) is formed, which auto-
catalytically activates caspase-8. Activated caspase-8 will then cleave and activate caspase-3 and 
BH3-interacting domain (BID). BID cleavage will activate the intrinsic apoptotic pathway (101). 
The intrinsic pathway of apoptosis receives stress signals such as DNA damage from 
within the cell and is triggered at the mitochondria. These stress signals induce mitochondrial 
outer-membrane permeabilization (MOMP) which allows the release of cytochrome c and 
SMAC/Diablo from the intermembrane space to the cytoplasm. Cytochrome c associates with 
apoptosis protease-activating factor 1 (APAF-1) causing oligomerization to form the 
apoptosome, which binds and activates caspase-9. Activated caspase-9 in turn cleaves and 
activates the effector caspase-3 and -7 which elicit the apoptotic phenotype by proteolytic 
cleavage of their targets (102). 
The B-cell lymphoma 2 (Bcl-2) family of proteins plays a central role in apoptosis 
regulation. Bcl-2 family members can be either pro- or anti-apoptotic, and are characterized by 
the presence of at least one of four Bcl-2 homology (BH) domains (see table 1) (103). The anti-
apoptotic members of the Bcl-2 family contain four BH domains (BH1-4). Major members of the 
anti-apoptotic group include Bcl-2, Bcl-2-related gene, long isoform (Bcl-xL), and myeloid cell 
leukemia 1 (MCL-1). The anti-apoptotic Bcl-2 proteins preserve the integrity of the outer-
member of the mitochondria by inhibiting the activity of some of the pro-apoptotic Bcl-2 
proteins. The pro-apoptosis members of the Bcl-2 family can be subdivided into 2 groups: 1) the 
effector proteins that oligomerize at the mitochondrial outer membrane to cause MOMP, and 
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which include Bcl-2 antagonist killer 1 (BAK) and Bcl-2-associated x protein (Bax), and 2) the 
BH3-only proteins which can interact with the anti-apoptotic proteins and sensitize cells to 
apoptosis, like Bcl-2 antagonist of cell death (Bad), and those that can interact with either the 
anti-apoptotic and the effector Bcl-2 family proteins to induce apoptosis, such as Bcl-2-
interacting mediator of cell death (BIM) (102, 104).  Some of these Bcl-2 proteins (Mcl-1 and 
Bcl-xL) have a proline, glutamic acid, serine and threonine-rich (PEST) sequence, which targets 
proteins for degradation either by caspases or by proteosomal degradation (105). In the case of 
Bcl-xL, the PEST sequence is revealed by deamination (106). However, a recent report in Mcl-1, 
which contains BH1-3 domains, identified the F3 peptide sequence within the BH1 domain as 
being required for protein degradation, not the PEST sequence (107).  
Table 1 – Comparison of Bcl-2 Protein Structures 
 Domains Present Protein Name 
Anti-Apoptotic, multi-domain BH4, BH3 BH1, BH2, TM 
(PEST•) 
Bcl-2, Bcl-xL•, MCL-1•, Bcl-
w, Bfl-1, Bcl-B, A1 
Pro-Apoptotic, multi-domain, BH3, BH1, BH2, TM Bax, Bak, Bok 
Pro-Apoptotic, BH3-only BH3 (TM*) Bad, BID, Bim, Puma, Gad, 
Noxa, Hrk, Bik, Bfm, Bcl-G, 
Spike, Bcl-XS 
•PEST domain-containing protein* Some BH3-only proteins do not have trans-
membrane domains. TM: trans-membrane domain. BH: Bcl-2homology domain, 
MOM: mitochondrial outer membrane, PEST: proline, glutamic acid, serine, 
threonine-rich sequence. 5 
The translocation of Bax to mitochondria, the release of cytochrome c and SMAC/Diablo 
to the cytosol and the subsequent caspase-9 activation are cardinal events of the intrinsic 
apoptotic pathway, which can be triggered by glutamine deprivation (52, 53, 109-111).  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
5 Table 1 adapted from Yip et al, Chipuk et al, Dho et al and Garcia-Saez et al (102, 104, 106, 108). 
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1.7.2 — Glutamine Regulation of Apoptosis 
Glutamine has been shown to act as a signalling molecule in the regulation of apoptosis. 
As nutrients are being metabolized within a cell, ROS are being generated as a by-product. In 
order to counter the noxious effects of these reactive molecules, antioxidants are found within 
the cell to reduce ROS. Some of these antioxidants, such as GSH, which are regulated by the 
availability of glutamine. Another such molecule is manganese superoxide dismutase (MnSOD), 
which resides in the mitochondrial matrix. MnSOD catalyzed the conversion of superoxide (O2-) 
to peroxide (H2O2), which can then be reduced to water by GSH (112). In a recent report, Aiken 
et al showed that in essential amino acid deprivation, histidine depletion induced MnSOD 
expression, but only in the presence of millimolar levels of glutamine. They further demonstrated 
that these amino acids mediated their effects by signalling through the mTOR and MEK/ERK 
pathways and metabolic flux through the TCA was required, as was mitochondrial membrane 
potential, but that ATP was not concomitantly required, indicating that the requirement for these 
amino acids was not strictly based on the production of energy (109). 
In periods of stress, glutamine can have protective effects against stress-induced 
apoptosis. In rats after a 1h session of exercise, collected neutrophils had increased expression of 
p53 and caspase-3, and a higher level of phosphorylated p38 MAPK and JNK were detected 
when compared to controls. However, if the rats were fed glutamine prior to that session of 
exercise, there was only a partial upregulation of p38 and JNK phosphorylation and p53 
expression, and no increase in caspase-3 expression, indicating that glutamine provided some 
protection to exercise-induced apoptosis (113).  
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In HeLa cells deprived of glutamine, apoptosis could be induced by Fas ligation of its 
cognate receptor via the extrinsic apoptotic pathway (see figure 1.4), but not in normal cells. Fas 
ligation triggered apoptosis by activating apoptosis signal-regulating kinase 1 (ASK1) and JNK. 
Mechanistically, the suppression of Fas-mediated apoptosis by glutamine was mediated by the 
binding and inhibition of ASK1 by glutaminyl-tRNA synthetase. The interaction between ASK1 
by glutaminyl-tRNA synthetase was increased by the  availability of glutamine (114). 
Interestingly, in leukemia-derived HL-60 and CEM cells deprived of glutamine, the resulting cell 
shrinkage caused the clustering of CD95 receptors, activating the extrinsic pathway in the 
absence of ligand binding (34).  
In brain tissues, there exists a delicate balance between glutamine and glutamate. Excess 
glutamate or ammonium (derived from glutaminolysis) have been shown to induce apoptosis, so 
synthesis of glutamine to remove these metabolites from the extracellular space is desirable 
(115). However, excess glutaminolysis within mitochondria leads to the induction of the intrinsic 
apoptotic pathway, caspase-9 and -3 activation and nuclear fragmentation (116).  
1.8 — Autophagy and Its Regulation by Glutamine 
1.8.1 — The Molecular and Cellular Basis of Autophagy 
Autophagy is a process whereby cellular components are delivered to lysosomes to be 
degraded into their basic constituents (amino acids, nucleotides, etc.), which are recycled by the 
cell. There are 3 types of autophagy which can be differentiated by the substrates they degrade: 
chaperon-mediated autophagy (proteins that contain a KFERQ motif), microautophagy (using 
lysosomal membranes, targets specific organelles and portions of the cytosol) and 
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macroautophagy (using autolysomal membranes, targets mitochondria, ER, lipids, 
carbohydrates, ribosomes, peroxisomes and protein aggregates) (117, 118). The latter is the focus 
of this section and will be hereafter referred to as autophagy.  
While autophagy was originally classified as a type of cell death, it is now regarded as a 
survival response which can sometimes lead to cell death (119). Autophagy has been implicated 
in a wide range of cellular processes, from the degradation of bacteria, protein aggregates or 
aberrant organelles to homeostasis maintenance to anti-tumourigenesis (120-123). The 
degradation products are shuttled back to the cytoplasm and recycled into other macromolecules 
or metabolized; this is especially useful when cells are under conditions of stress from infection, 
hypoxia or starvation (124). 
The molecular machinery used in autophagy was identified in yeast using mutations of 
the autophagy related genes (Atg). There are 31 Atg genes, which are highly conserved in 
eukaryotes. Of those 31 Atg genes, 18 are considered to encode core proteins of the autophagic 
machinery, and they can be further subdivided into four different groups: the Atg1/unc51-like 
kinases (ULK) with their regulators, Vps34/class III PI3K complex I; the Atg9/mAtg9 cycling 
complex; and the ubiquitin-like systems of Atg12 and Atg8 (124). For clarity, the mammalian 
autophagy nomenclature will be used from this point on.  
The current model of autophagy can be described in five steps which are depicted in 
figure 1.5: 1) the initiation of phagophore formation (Vps34-Beclin-1 and Atg-13, Atg-17 and 
Atg-1 kinase/Ulk1) at or near the ER (125, 126); 2) the ubiquitin-like conjugation of Atg-5 to 
Atg-12; 3) the ubiquitin-like conjugation of phosphatidylethanolamine (PE) to LC3B-I to form 
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LC3B-II; 4) cargo selection; and 5) the fusion of the autophagosome to lysosomes and the 
degradation of its content (119, 127, 128).  
 
Figure 1.5 - Autophagosome Formation 
This figure provides a visual representation of the autophagosome formation, 
closed and loaded with cargo. The molecular pathways are presented in the 
context of their place in the autophagosome formation6.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
6 Figure 1.5 adapted from Glick et al (119). 
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Since the first identification of autophagosomal structures in the 1960s, there has been 
much debate as to the origins of the membranes used to construct autophagosomes with no 
definitive answer to date. There are two current models: the first model postulates that the 
membranes are sourced from pre-existing organelle membranes (129), while the second model 
postulates de novo formation of autophagosomal membranes (130). Some of the organelles that 
have been reported to provide membranes for the formation of autophagosomes are the ER, 
mitochondria, endosomes, the plasma membrane and the Golgi apparatus (129-134).  
In order for cargo included in autophagosomes to be degraded, the latter must fuse to 
lysosomes or endosomes to produce the degradative autolysosomes. Once in the autolysosomes, 
the cargo is degraded by proteolysis and acidification (135). The presence of proteases such as 
cathepsins L, B and D, is critical to the proper turnover of autolysosomal contents and 
termination of autophagy. In mouse models deficient in either cathepsin D or L/B, severe 
neurodegenerative diseases were observed (136). 
1.8.2 — Autophagy Regulation by Amino Acid Availability 
Cells exist in a delicate balance of signals, and are continuously monitoring their 
environment. Growth and proliferation will occur when the extracellular environment contains 
the appropriate conditions to sustain proliferation, but in a restrictive environment, cells will 
forgo proliferation to favour maintenance. 
Protein Kinase A (PKA) is part of a nutrient-sensing pathway which responds to 
cytoplasmic levels of cyclic AMP (cAMP). When cAMP is elevated in response to the presence 
of glutamine (137), it increases the activity of glutamine-fructose-6-phosphate amidotransferase 
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(GFAT), the rate-limiting step of the hexosamine pathway in a PKA-dependent manner (see 
figure 1.1) (138).  PKA can directly phosphorylate LC3 to inhibit autophagy induction. A recent 
study in neuronal cells demonstrated that a pool of PKA-phosphorylated LC3 was readily 
available, enabling cells to rapidly mediate the induction of autophagy in response to stresses 
like nutrient deprivation or injury, but had no effect on vacuoles that were already formed. This 
PKA LC3 phosphorylation site was not observed in the yeast or Drosophila melanogaster, was 
present in all mammalian forms of LC3, but not on Atg8 homologues GABARAP and GATE16 
(139). 
In favourable conditions (i.e., when nutrients are plentiful), class I PI3Ks are activated, 
along with Ras, by growth factor binding to their cognate tyrosine kinase receptor to initiate cell 
growth and proliferation (see figure 1.6). PI3Ks catalyse the phosphorylation of 
phosphatidylinositol 4,5 biphosphate (PIP2) to phosphatidylinositol 3,4,5 triphosphate (PIP3) 
(140). This activity at the lipid membrane creates docking sites for both AKT and its activator, 
phosphoinositide-dependent protein kinase-1 (PDK-1).  
The activation of AKT can be prevented by the activity of phosphatase and tensin 
homolog (PTEN), which dephosphorylates PI3P into PI2P. Active mTOR inhibits the initiation 
of autophagy by phosphorylating Atg-13 to prevent its interaction with Atg-1, thereby blocking 
phagophore formation and providing a link between autophagy and the energy status or growth 
signals (119, 128, 141). AKT can inhibit autophagy by both activating mTORC1 through 
phosphorylation and by directly decreasing UVRAG expression in a kinase-independent manner 
(142). Ras activation leads to activation of extracellular signal-regulated kinase (ERK), which 
phosphorylates and destabilizes the tuberous sclerosis complex 1/2 (TSC1/TSC2), allowing 
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mTORC1 catalytic activation by phosphorylating the mTOR activator Ras homologue enriched 
in brain (Rheb) (143-147).  
In many tumours, autophagic activity is decreased. This can be attributed to the fact that 
many oncogenes, like AKT, PI3K (type I) and pro-survival Bcl-2 family members such as Bcl-2, 
which can bind Beclin-1 to prevent autophagy initiation, are autophagic suppressors. Conversely, 
tumour suppressors like PTEN, tuberous sclerosis protein 2 (TSC2), p53 and death-associated 
protein kinase (DAPk), which are autophagy activators, are silenced (see figure 1.6) (6, 121, 
148-150).  
In primary liver cells of weaned calves, glutamine infusion increased the levels of 
autophagy in a dose-dependent fashion. Recent reports highlight the role of the PI3K-AKT-
Forkhead Box O (FOXO) module and glutamine metabolism in the regulation of autophagy. 
Upon growth factor removal, FOXO1, -3 and -4 transcription factors increased the expression 
and the activity of glutamine synthetase to repress mTOR activity and increase autophagy (see 
figure 1.6) (151-153).  
In unfavourable conditions, such as amino acid withdrawal, the binding of Rheb to 
mTORC1 is inhibited, preventing its activation (see figure 1.6) (147, 154). In order to be fully 
active, AKT must be phosphorylated in 2 sites; Ser473 by PDK-1 and Thr308 by mammalian 
target of rapamycin complex 2 (mTORC2) and DNA-dependent protein kinase (DNA-PK). 
Phosphorylation of AKT has been reported to be inhibited by several different stressors, 
including the unfolded protein response (via GRP78) (153), and thereby allowing autophagy to 
occur. Constitutive activation of the Ras pathway has been reported to bypass mTORC1 
inhibition in amino acid deprivation in a melanoma cell line and to have abnormal autophagy 
 27!
signalling (155). Additionally, Ras-transformed cells, like myc-transformed cells, have an 
increased dependence on glutamine for growth and survival and activate and rely on autophagy 
to provide with biosynthetic precursors for proliferation, growth and survival (156-160). 
However, autophagy triggered by amino acid deprivation is dependent on the ULK1/2 for 
initiation (92). 
 
Figure 1.6 - Extracellular Signals Regulate mTOR 
The activity of mTOR is affected by signals received to indicate the availalility of 
nutrients for growth and proliferation Signalling molecules that transduce the 
signal to proliferate, such as AKT or Ras, will activate mTOR, whereas in 
unfavourable conditions, like amino acid withdrawal or the unfolded protein 
response (UPR), PTEN and TSC2 will prevent mTOR activation7.  
A recent report described the role of DAPk in cells under oxidative stress in the 
activation of the serine/threonine kinase protein kinase D1 (PKD), which in turn binds and 
phosphorylates Vps34 to activate autophagy (123). The ectopic presence of PKD alone was 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
7 Figure 1.6 adapted from Kim et al, Demetriades et al and Avruch et al (87, 147, 154). 
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sufficient to trigger autophagosome formation, and the activation of PKD by DAPk was 
independent of PKC (123, 161). This ability of ROS to induce autophagy may be critical in the 
tumour environment where cells at the center of a mass do not have access to all the nutrients 
available to the cells on the tumour periphery. 
In intestinal epithelial cell lines, glutamine increased the formation of autophagosomes 
and led to an inhibition of mTOR and p38 MAP kinase. Upon glutamine deprivation, the ability 
of intestinal epithelial cells to recover from heat shock was severely impaired and apoptosis was 
induced (162). In a heat stress model, glutamine conferred a protective effect by signalling 
through the PI3K-AKT pathway to increase heat shock protein 70, prevent the expression of 
fibronectin-integrin and desphosphorylate p38 MAPK, a downstream effector of fibronectin-
integrin signalling (163, 164). Under nutrient-limiting or starvation conditions, the high 
AMP:ATP ratio leads to the activation of AMP-activated protein kinase (AMPK) activity, which 
will inhibit cell growth and proliferation and allow autophagy to occur by acting as metabolic 
checkpoint (see figure 1.7). This occurs in part through the inhibition of mTORC1. This is 
accomplished by phosphorylation of both Raptor and TSC2, blocking the kinase activity of 
mTORC1 (165). In addition to removing the inhibitory activity of Raptor and TSC2 on 
mTORC1, AMPK can directly phosphorylate and activate ULK1 and Beclin-1 (166, 167). Direct 
AMPK phosphorylation of Vps34 will inhibit its activity. However, Atg14L inhibits AMPK 
phosphorylation of Vps34 and stimulates AMPK phosphorylation of Beclin-1 (168). Combined, 
these effects would inhibit the activities of other, non-autophagy related Vps34 complexes while 
promoting the activity of complex I during autophagy initiation.  
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1.8.3 — Ammonium Ion Signalling in Autophagy Regulation 
There has been much speculation as to how glutamine could affect autophagy. A by-
product of glutaminolysis is the release of ammonium ions (6). Recently, a report described the
 
Figure 1.7 - mTORC is an Autophagy Molecular Switch 
The regulation of autophagy is highly dependent on the activity of mTORC. 
Signalling molecules that transduce the signal to proliferate, such as AKT or 
MAPK will activate mTORC and suppress autophagy initiation. Signalling 
molecules that are activated in times of cellular stress, like AMPK (low energy) 
and p53 (DNA damage), suppress the autophagy inhibitory activity of mTORC to 
allow autophagy to proceed. 
importance of glutamine-derived ammonium ions as a regulator of autophagy (169). In this 
report, cells cultured in glutamine-supplemented medium for more than 48h displayed increases 
in autophagy. Conditioned medium from this cell culture was then added to a fresh culture and 
an increase in autophagy was also observed. The autophagy-stimulating compound was 
identified as ammonium ions and conferred a protective effect against nutrient deprivation and 
TNF-α induced apoptosis (169). The effect observed was not induced by a pH change and was 
thought to be significant in tumour microenvironments where nutrient deprivation could occur 













or chemotherapy (6, 169). Eng et al. collected and analyzed the interstitial fluids of human 
tumours xenografts and found the concentration of ammonium ions, in the millimolar range, to 
be significantly elevated when compared to the plasma levels of the murine host (169). Because 
of their size and chemical properties, ammonium ions are easily diffusible. This is particularly 
noteworthy when one considers that the tumour microenvironment can vary drastically. Cells 
exposed on the outer layer of the tumour may be in a nutrient rich environment, consuming 
glutamine and excreting ammonium ions, which could diffuse to the inner reaches of the tumour 
where nutrients may not be as plentiful due to poor vascularisation to stimulate autophagy as a 
pro-survival mechanism.  
While the induction of autophagy by rapamycin is mTOR-dependent, autophagy induced 
by ammonium ions is mTOR-independent. In double-knockout ULK1/2(-/-) mouse embryonic 
fibroblasts, the induction of autophagy in response to amino acid deprivation was inhibited, but 
not in response to glucose deprivation or to inhibition of glucose metabolism. In this model, 
autophagy induction in response to glucose deprivation was associated with an increase in the 
ammonium ions concentration arising from an increase in amino acid catabolism in an Atg-5-
dependent manner (92). This would indicate that autophagy provides cells with an adaptation 
response to both excess (ULK1/2-independent) and deprivation (ULK-1/2 dependent) of nitrogen 
sources.  
In a recent report, quantitative phosphoproteomics was used to assess the signalling 
pathways that are modulated by ammonium ion-stimulated autophagy, using rapamycin as a 
comparator, in MCF-7 breast cancer cells. This report confirmed that mTOR was not affected by 
the induction of autophagy by ammonium ions, and pointed to the upregulation of AMPK and 
the unfolded protein response as the primary driver of autophagy. Ras signalling, more 
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specifically MAPK3 activity, was increased (170). Ammonium ion-induced elevation in 
MAPK1/3 activity had been previously reported in rat astrocytes (171, 172). Furthermore, 
ammonium ion treatment stimulated Rho GTPase protein signal transduction, which is crucial to 
the actin cytoskeleton plasticity and is involved in processes such as proliferation, motility and 
apoptosis. The ability of ammonium pre-treatment to stimulate cell motility was assessed in a 
wound closure experiment and was found to require MAPK3 activity (170).  
1.9 — Cross-talk Between Apoptosis and Autophagy 
The balance between autophagy and apoptosis is not as clear as was once believed but 
there is evidence of crosstalk between the two processes (173, 174). For example, the Vps34-
Beclin-1 interaction is inhibited by the binding of anti-apoptotic proteins Bcl-2 family members 
to Beclin-1 through their BH3 domain (175). In response to anticancer treatment, calpain cleaves 
Atg-5 to inhibit autophagy, but the cleavage product translocates to mitochondria to interact with 
Bcl-xL, allowing cytochrome c release and the initiation of apoptosis (176). Moreover, Vps34, 
Beclin-1 and Atg4 have been reported to be substrates of caspases (177). p53 is another link 
between apoptosis and autophagy: in response to adverse cellular conditions such as DNA 
damage and hypoxia, nuclear p53, a known modulator of apoptosis (178), transactivates the β1 
and β2 subunits of AMP-activated protein kinase (AMPK) which inhibits mTOR, which in turn 
promotes autophagy (179). The relocation of p53 from the nucleus to the cytoplasm has been 
shown to induce mitochondrial outer membrane permeabilization, allowing cytochrome c release 
and the induction of apoptosis (150, 180). In a recent report, Rovetta et al explored the roles of 
autophagy and apoptosis in renal toxicity to cisplatin. At low doses of cisplatin, autophagy was 
cytoprotective, and its inhibition resulted in increased apoptosis. A high-dose of cisplatin 
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induced apoptosis unless cells were pre-treated with an autophagy inducer which protected cells 
against death (181). 
Autophagy is inhibited by Bcl-2 binding to Beclin-1 monomers or dimers (see figure 1.8) 
and any protein modifications that weakens this interaction stimulates the progression of the 
autophagic process. DAPk can phosphorylate Beclin-1 in its BH3 domain to promote 
dissociation of Bcl-2 (182, 183). Bcl-2 can be phosphorylated by c-Jun N-terminal kinase 1 
(JNK1) and ERK, both mitogen-activated protein kinases (MAPK), to destabilize its interaction 
with Bcl-2/Bcl-xL, allowing phagophore formation (182, 183). As both of these kinases are 
stress-activated kinases, their role in mediating the starvation-induced stress signal is not 
surprising (131, 161, 184). 
 
Figure 1.8 - Bcl-2 Family Members Play a Role in Autophagy Regulation 
Beclin-1 contains a BH3 domain which allows the binding of Bcl-2 family 
members. This association will inhibit the ability of Beclin-1 to form interaction 
in Complex I or II. The ability of Bcl-2 to bind and inhibit Beclin-1 activity is 
impaired by stress signals such as those transduced by DAPk and MAPK. 
DAPk is one of the few regulators of autophagy that seems to be restricted to the 
induction of autophagic cell death. Because it is also implicated in apoptotic membrane blebbing 








(185). DAPk also interacts with microtubule-associated protein 1B (MAP1B) to allow LC3 
processing. DAPk has been reported to allow the stabilization of p53 via p19 (ARF). Since this 
causes the nuclear accumulation of p53, and p53 transactivates genes for apoptosis, continued 
signalling via DAPk may tip the balance from autophagy to apoptosis. Many of the pro-apoptotic 
Bcl-2 family members, such as Bad, Bax and PUMA, have been implicated in the induction of 
autophagy. It is hypothesized that this induction is mediated by destabilizing the Beclin-1 and 
Bcl-2 or Bcl-xL interactions (148).  
GADD-153 has recently been implicated in autophagy, even though it is typically 
associated with apoptosis in response to ER stress. GADD-153 is a transcription factor that was 
first identified in models of growth arrest or DNA damage; GADD-153 is highly upregulated in 
stress conditions, particularly in ER stress and nutrient starvation such as glutamine and glucose 
deprivation (186-190). Proteins that are destined for secretion or shuttled to other cellular 
compartments such as lysosomes, the Golgi apparatus or the cell membrane are folded in the ER. 
The accumulation of unfolded proteins signal ER stress and activates UPR pathways. The UPR 
can downregulate protein synthesis, activate transcription factors to upregulate chaperones, such 
as GRP78, to allow for the proper folding of proteins. If this response is not sufficient to relieve 
the ER stress, then other factors, such as GADD-153 expression, are activated or upregulated. 
This upregulation has been reported to downregulate the expression of Bcl-2 and GSH and lead 
to apoptosis (181, 191). In models for atherosclerosis, diabetes, Alzheimer's and Parkinson, 
upregulation of GADD-153-induced apoptosis was suggested as being a contributing factor to 
disease progression (186, 192-194). One report using chemotherapeutic agents known to induce 
either autophagy or apoptosis describes the upregulation of GADD-153 in both phenomena. In 
both cases, the cell viability decreased with GADD-153 expression. The functional contribution 
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of GADD-153 was confirmed using gene-silencing and overexpression studies. Exogenous 
expression of GADD-153 in their cell model of human gliomas induced apoptosis and autophagy 
in the absence of any other form of stimulation (195). In a study of embryonic stem cells, the 
authors support GADD-153 as being an intermediary between autophagy and apoptosis by 
increasing the expression of Bax/Bak and decreasing the expression of Bcl-2 and Bcl-xL. This 
alone would allow autophagy to occur by releasing Beclin-1 from its inhibitory interactions with 
anti-apoptotic Bcl-2 family members (196). 
1.10 — A Cellular Model to Study Glutamine Signalling 
The overall conclusion that can be gleaned from the literature is that glutamine is more 
than just an amino acid. It is a signalling molecule that plays an important role in cell survival, 
allowing cells an opportunity to adapt to stressful conditions though the activation of essential 
pathways. As such, the availability of glutamine is an important determinant to cell fate. 
Previous work in the Sp2/0 hybridoma cell line has shown that these cells respond to the 
levels of glutamine available in the culture medium (110, 197). In order to assess whether that 
sensitivity was general to all amino acids or specific to glutamine, Sp2/0 cells were cultured in 
medium containing all but 1 of the 20 amino acids and cell viability was assessed at 4h and 24h. 
The withdrawal of glutamine for 4h was enough to induce rapid apoptosis along the intrinsic 
pathway (53). This effect was specific to glutamine, as the withdrawal of any of the other 19 
amino acids did not significantly affect cell survival. The induction of the intrinsic pathways of 
apoptosis was confirmed by translocation of Bax from the cytosol to the mitochondria, cytosolic 
release of cytochrome c and SMAC/Diablo after 60 min, and activation of caspase-9, and 
caspase-3 (53, 110). Other types of cells typically require longer culture periods in the absence of 
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glutamine before cell death is induced, such as human neuroblastoma cells where cell death was 
observed at 48h, or human leukemia or lymphoma cell lines, CEM (lymphoblastic leukemia), 
Namalwa (Burkitt's lymphoma), U937 (histiocytic lymphoma) and HL-60 (pro-myelocytic 
leukemia), where death was observed between 24 to 48h (50, 198). This rapid induction of 
apoptosis made the Sp2/0 cell line a singularly suitable model to study intracellular signalling 
induced by modulations of glutamine levels and supported the role of glutamine as a survival 
signal.  
Interestingly, the Sp2/0 cell line expresses few of the anti-apoptotic members of the Bcl-2 
family members (Bcl-2, Bcl-W, Mcl-1 and Bfl-1) and with the exception of Mcl-1, expresses 
them at low levels (111) while expressing many pro-apoptotic family members (Bax, Puma, Bim 
and Bad), and these at higher levels (figure 1.9). Because of the higher ratio of pro-apoptotic 
members to anti-apoptotic members, Sp2/0 are poised to undergo apoptosis. This also means that 
there are few anti-apoptotic members to inhibit autophagy inhibition by binding Beclin-1. The 
ectopic presence of Bcl-xL was shown to be sufficient to prevent apoptosis (199), but had the 
effect of decreasing Sp2/0 cell proliferation, even in the presence of glutamine (110).  
In the Sp2/0 cell cultures, glutamine withdrawal leads to an increased production of 
reactive oxygen species (ROS) and a concurrent decrease in GSH levels, causing oxidative stress 
as seen in other cell lines, such as mouse embryonic fibroblasts, human glioblastoma, breast and 
colon epithelial cells (90, 200, 201). However, this oxidative stress was not sufficient to cause 
cell death. The use of the antioxidant N-acetyl-L-cysteine (NAC) did not prevent the activation 
of apoptosis in glutamine withdrawal, as caspase-3 was activated and cell viability was lost. 
Interestingly, the number of apoptotic bodies was decreased in the presence of NAC. NAC 
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decreased the phosphorylation of p38, indicating that ROS were involved in the formation of 
apoptotic bodies by the activation of p38 MAPK (199, 200). 
 
Figure 1.9 - Expression of Bcl-2 Family Proteins in Sp2/0 Cells 
This Western blot panel depicts the expression of the various Bcl-2 family 
members as expressed in the Sp2/0 cell line (Jurkat lymphoid T cell line and 
HeLa fibroblast cell line were used comparison purposes). The left panel contains 
the anti-apoptotic Bcl-2 family members, and the right panel contains the pro-
apoptotic Bcl-2 family members. Figure courtesy of CC Harnett and ER Gauthier.  
In Sp2/0 cells that ectopically expressed Bcl-xL, p38 phosphorylation was inhibited 
during glutamine starvation. This would indicate that this phosphorylation event is induced after 
the mitochondria exhibit signs of dysfunction. Additionally, the inhibition of caspase activity 
using the pan-caspase inhibitor Z-VAD-fmk did not prevent p38 phosphorylation, indicating that 
this event is caspase-independent. The activation of p38 MAPK was involved in the induction of 
late apoptotic features, but not in the initiation of apoptosis in glutamine starved Sp2/0 cell 
cultures (199).  
The Sp2/0 cell line expresses AKT1 and AKT3, but also expresses PTEN, a PI3K 
pathway inhibitor. Fully active AKT is phosphorylated at 2 critical sites, T308 and S473. When 
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assessed in Sp2/0 cells under normal culture conditions, AKT was found to remain 
unphosphorylated at those sites (see figure 1.10). Moreover, Sp2/0 cells exhibit high levels of 
deregulated c-myc (60). Since c-Myc drives glutaminolysis by increasing the expression of 
glutamine transporters and GLS to provide fuel for the TCA cycle and biosynthetic precursors 
while releasing ammonium ions (section 1.8.3), these cells are dependent on glutamine for 
survival (52, 54, 59). As the presence of activated AKT would also stimulate glucose import and 
the Sp2/0 cells are AKT-deficient, these two factors combined may in part explain the glutamine 
dependence of the Sp2/0 cell line (4, 53, 110).  
 
Figure 1.10 - Expression and Phosphorylation Levels of AKT in Sp2/0 cells 
This Western blot panel depicts the expression levels of the different AKT 
isoforms in the Sp2/0 cell line and in Jurkat lymphoid T cell line and HeLa 
fibroblast cell line as a comparison. The Western blot also assessed the 
phosphorylation states at 2 critical phosphorylation sites on AKT (S473 and 
T308). Figure courtesy of CC Harnett and ER Gauthier. 
1.11 — Project Hypothesis 
The Sp2/0 cell line expresses many pro-apoptotic and fewer anti-apoptotic Bcl-2 proteins 
and is constantly poised on the brink of apoptosis and will undergo apoptotic death rapidly upon 
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induction (53). The lack of Bcl-xL expression and relatively low expression of Bcl-2 also 
provides fewer avenues of autophagy inhibition (202). It is myc-transformed and highly 
proliferative, making it dependent on glutamine for cell survival (203). Using this cellular model, 
this body of work was focused on elucidating the relationship between glutamine, proliferation 
and survival. The project hypothesis is that the presence of glutamine acts as a signalling 
molecule and is necessary for survival and proliferation in Sp2/0 cells. It is postulated that Sp2/0 
cell survival requires autophagy, which will be modulated by glutamine availability.  
The study had 3 main objectives: 1) to evaluate the effects of glutamine limitation, rather 
than deprivation, on Sp2/0 cell behaviour, including cell survival, apoptosis and the effects on 
the cell cycle both as an endpoint and over a 24h period, 2) to evaluate the presence of autophagy 
in the Sp2/0 cell line in glutamine-rich and glutamine limiting conditions and 3) to evaluate the 
effects of ammonium, the by-product of glutaminolysis, on cell behaviour in glutamine-limiting 
conditions.  
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2.0 — MATERIALS AND METHODS 
2.1 — Reagents and Antibodies 
Unless stated otherwise, all reagents were obtained from Sigma-Aldrich Canada 
(Oakville, ON). Glutamine solutions were freshly prepared as a 200 mM stock in phosphate 
buffered saline with the pH adjusted to 7.4. (PBS; 9.1 µM Na2HPO4, 1.7 mM NaH2PO4, 150 mM 
NaCl, pH 7.4).  
Propidium iodide was prepared at a concentration of 1mg/mL for flow cytometry 
staining. 3-methyladenine (3-MA) was prepared in double distilled water (ddH2O) as a 100 mM 
stock solution. Stock solutions for rapamycin (100 µM) and bafilomycin A1 (100 µM) (both 
from Cell Signaling Technology, Danvers, MA) and caspase inhibitor Z-VAD-fmk (10 mM) 
(EMD Chemicals, San Diego, CA) were prepared in DMSO. 
DMSO was used as the treatment control in experiments using Bafilomycin A1, 
rapamycin and Z-VAD-fmk, and ddH2O was used as the treatment control for the 3-MA 
experiments. 
Antibodies raised against the following proteins were from Santa Cruz Biotechnologies 
Inc. (Santa Cruz, CA): cytochrome c, GADD-153 (clone B3), GRP78, PARP and HSP60. 
Antibodies against cleaved caspase-3, Atg12, β-actin, LC3B and PTEN were from Cell Signaling 
Technology (Danvers, MA). 
 40!
2.2 — Cell Culture 
The Sp2/0-Ag14 (Sp2/0) mouse hybridoma cell line was obtained from the American 
Type Culture Collection (ATCC, Rockville MD) and maintained in Iscove's Modified 
Dulbecco's Medium (IMDM) supplemented with 5% Fetalclone I (Hyclone, Logan UT), 
100U/mL penicillin, 100 µg/mL streptomycin and 4 mM L-glutamine (Q) (hereafter designated 
as complete IMDM) in 37oC, 5% CO2 humidified atmosphere. The generation of Sp2/0 cells 
transfected with Bcl-xL and the control vector pTEj8 was described earlier, and Sp2/0 cells 
transfected with Bcl-xL or the pTEJ8 vector were maintained in complete IMDM containing 750 
µg/mL G-418 (110, 111). 
All assays were performed using Sp2/0 cells in the exponential growth phase which were 
washed twice in warm (37oC) IMDM containing 5% Fetalclone, 100U/mL penicillin and 100 
µg/mL streptomycin, but not supplemented with L-glutamine (hereafter referred to as glutamine-
free IMDM). The cells were then seeded at 4x105 cells/mL in glutamine-free IMDM medium, 
supplemented with selected drugs (or their solvent control) and cultured for the indicated period 
of time. Corresponding controls supplemented with 4 mM L-glutamine were also prepared in 
parallel.  
2.3 — Cell Viability Assays 
Cell viability was assessed using the trypan blue exclusion assay. In a trypan blue 
staining assay, cells that do not maintain their membrane integrity will stain blue and can be 
visualized by light microscopy. The staining occurs because the chromophore is negatively 
charged and cannot interact with the cell membrane unless there is damage (204). The 
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percentage of cells that do not stain gives an indication of cell viability. Cell suspensions were 
stained with 0.4% trypan blue solution for 5 min at room temperature, then 10 µL were loaded 
into the chamber of a Neubauer haemocytometer (Fisher Scientific, Ottawa, Ontario) and placed 
on an inverted microscope under a 10X objective, using phase contrast. The number of unstained 
and stained (blue) cells was determined and cell viability was expressed as the percentage of 
white cells (viable) to the total number of cells (white + blue). Cell density was determined using 
the white cell counts multiplied by 1x104 to estimate the number of cells/mL, as per the 
manufacturer’s instructions. An average of 4 counts were taken for each sample or condition. 
As a complementary approach to determine Sp2/0 cell viability, treated cells were 
subjected to a clonogenic assay. After subjecting the cells to glutamine starvation or limitation, 
the cell density was adjusted to 5 cells/mL in complete IMDM before 100 µL of this dilution was 
seeded in a 96 well plate. Cells were allowed to grow for 7 to 10 days, and the number of wells 
containing colonies of at least 50 cells was counted.  
2.4 — Flow Cytometry 
To analyse cell cycle distribution, cultured Sp2/0 cells were collected, incubated on ice 
for 10 min, washed twice with ice cold PBS before being permeabilized in ice-cold 70% ethanol. 
Cells were stained with propidium iodide (0.1mg/mL propidium iodide, 0.3% IGEPAL, 0.1% 
sodium citrate and 0.04 µg/mL RNAse A) for 1h at room temperature before flow cytometry 
analysis.  
Detection of early apoptosis was performed using the Annexin V/propidium iodide (PI) 
assay kit as per the manufacturer's instructions (BioVision, Mountain View, California) or with 
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Annexin V-FITC (BioVision) and 7-aminoactinomycin D (7-AAD, 0.25 µg/test, eBiosciences, 
San Diego, CA) incubated in the dark at room temperature for 5 min before analysis by flow 
cytometry. 
Flow cytometry experiments were performed using a BD FACSCanto II instrument and 
the BD FACSDiva flow and analysis software (BD Biosciences, Mississauga, On) with an argon 
ion laser, using the FL1 filter for Annexin V, the FL2 filter for propidium iodide and the FL4 
filter for 7-AAD. All experiments were performed after single colour compensation.  
2.5 — Determination of Caspase Activity 
Sp2/0 cells were treated as indicated and collected by centrifugation at 300 x g for 5 min 
at room temperature. Protein extracts were prepared and subjected to caspase-3 colorimetric 
enzymatic cleavage assay of a synthetic peptide (DEVD-pNA) as per the manufacturer's 
instructions (BioVision Inc. Mountain View, CA). This peptide contains a sequence, DEVD, 
which is preferentially recognized and cleaved by caspase-3 releasing p-nitroaniline (pNA) 
which can be measured by spectrophotometry at 405 nm. Optical density readings were obtained 
using a PowerWave X microplate spectrophotometer (BioTek Instruments Inc., Winooski, VT). 
2.6 — Western Blot Analysis 
Whole cell protein extracts for Western blot analysis were prepared using RIPA buffer (1 
% IGEPAL, sodium deoxycholate (12.1 µM ), sodium dodecyl sulfate (3.45 mM), Halt protease 
inhibitor cocktail (1X) (Fisher Scientific), sodium fluoride (50 mM), sodium orthovanadate (0.2 
mM), phenyl methyl sulfonyl fluoride (0.1mg/mL) in PBS) (53). Briefly, 10-20x106 cells were 
 43!
washed in PBS and centrifuged twice for 10 min at 300 x g at 4°C. Supernatants were discarded, 
the cell pellets were resuspended in 100 µL RIPA buffer and incubated on ice for 30 min. The 
cell pellets were then subjected to 3 freeze (-80°C for 5 min) and thaw (room temperature water 
bath) cycles. The cell pellets were further incubated on ice for 30 min, then centrifuged at 15 000 
x g for 20 min at 4°C. The total cell lysate contained in the supernatants were transferred to a 
clean tube and stored at -80°C until needed.  
For PARP and GADD-153, whole cell proteins extracts were obtained using a urea lysis 
buffer (205). Briefly, cells were washed in ice-cold PBS twice, then 5x105 cells were 
resuspended in urea lysis buffer (62.5 mM Tris-HCl, pH 8.6, 6 M urea, 10% glycerol, 2% 
sodium dodecyl sulfate, freshly added 5% β-mercaptoethanol, 0.00125% bromophenol blue). 
Cells were then lysed by sonication on ice for 15 s using a Model 50 Sonic Dismembrator 
(Fisher Scientific) and incubated for 15 min at 65°C before fractionation by SDS-PAGE.  
For cytosolic protein extracts, 5x107 Sp2/0 cells were collected by centrifugation (500 x 
g, 5 min) and incubated on ice for 15 min, washed twice in cold PBS, permeabilized with 250 µL 
of buffer A (KCl (75 mM), NaH2PO4 (1 mM), Na2HPO4 (8 mM), sucrose (250 mM), digitonin 
(230 µg/mL)) and incubated on ice for 10 min (206). An aliquot was taken and permeabilization 
was assessed by trypan blue exclusion assay. Cells were then centrifuged at 15 000 x g, 4°C for 5 
min. The supernatants (cytosolic fraction) were collected and centrifuged at 15 000 x g, 4°C for 5 
min, then mixed with an equal volume of 2X RIPA buffer for storage at -80°C. 
Proteins were fractionated by SDS-PAGE on a 12% mini-gel (separating gel: 12% 
acrylamide, 0.375M Tris-HCl, 0.1% SDS, pH 8.8, polymerized with 28.9 mM APS and 40 µL 
TEMED; stacking gel: 3.9 % acrylamide, 0.125M Tris-HCl, 0.1% SDS, pH 6.8, polymerized 
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with 14.45 mM APS and 20 µL TEMED) in an SDS electrophoresis buffer (Tris-HCl (0.125 M), 
glycine (0.96 M), 0.5% SDS, pH 8.3) for 60 min at 75mA (207).  
For the analysis of Cytochrome c and LC3B, proteins were fractionated by SDS-PAGE 
(separating gel: 12% acrylamide, 1 M Tris-HCl with 0.1% SDS, pH 8.45, and 13% glycerol, 
polymerized with 28.9 mM APS and 40 µL TEMED; stacking gel: 3.89% acrylamide, 0.31 M 
Tris-HCl with 0.07% SDS, pH 8.45, polymerized with 14.45 mM APS and 20 µL TEMED) 
using a tris-tricine buffer system (anode buffer: 0.04M Tris-HCl, pH 8.9; cathode buffer: 0.01M 
Tris-HCl, 0.1M Tricine, 3.47 mM SDS) (208) for 210 min at 30mA.  
After fractionation, proteins were transferred onto Immobilon PVDF membranes 
(Millipore Corporation, Billerica, MA) with a Tris-glycine transfer buffer (48 mM Tris-HCl, 39 
mM glycine with 20% methanol) using the Trans-Blot Semi-Dry Transfer Cell system (Bio-Rad 
Laboratories). To assess transfer efficiency, membranes were stained with Ponceau S (5% 
Ponceau S, 2% glacial acetic acid) for 15 min at room temperature followed by de-staining in 
distilled water prior to blocking. Membranes were blocked for 1h at room temperature with 5% 
non-fat dry milk or 5% bovine serum albumin, in TTBS buffer (0.02 M Tris-HCl, 0.14 M NaCl, 
0.1 % Tween 20, pH 7.6). Membranes were then incubated with mouse or rabbit primary 
antibodies following the conditions shown in Table 2. After three 5 min washes in TTBS, the 
membranes were incubated with anti-rabbit or anti-mouse IgG secondary antibodies coupled to 
horseradish peroxidase (HRP) diluted in TTBS containing 5% milk or BSA, and subjected again 
to three 5 min washes in TTBS. Detection was done by chemiluminescence using the Immobilon 
Western HRP Substrate Luminol reagent (Millipore). All images were captured using the 
Fluorchem 8000 imaging system and AlphaEase software (Alpha Innotech, San Leandro, CA). 
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Table 2 – Experimental Conditions Used for Each Antibody 






#7076 Cell Signaling Horse 1:3000 non-fat milk 
Anti-rabbit 
secondary 
#7074 Cell Signaling Goat 1:3000 non-fat milk 
β-actin #4967 Cell Signaling Rabbit 1:1000 Bovine serum 
albumin 
Caspase-3 #9662 Cell Signaling Rabbit 1:1000 non-fat milk 
Cytochrome c #4272 Cell Signaling Rabbit 1:200 non-fat milk 
GADD-153 #sc-7351 Santa Cruz Biotech Mouse 1:200 non-fat milk 
GRP78 #sc-13968 Santa Cruz Biotech Rabbit 1:200 non-fat milk 
HSP60 #sc-13966 Santa Cruz Biotech Rabbit 1:2000 non-fat milk 
LC3B #2775 Cell Signaling Rabbit 1:1000 Bovine serum 
albumin 
PARP-1 #9542 Cell Signaling Rabbit 1:1500 non-fat milk 
PTEN #9552 Cell Signaling Rabbit 1:1000 non-fat milk 
To assess protein loading into SDS-PAGE, mini-gels were stained for 1h with Coomassie 
Brillant Blue solution (0.1% Coomassie Brillant Blue, 40% methanol, 10% glacial acetic acid) 
then placed in de-staining buffer (50% methanol, 10% glacial acetic acid) at room temperature 
overnight. Protein extracts prepared in urea buffer were equalized following examination of 
Coomassie Blue-stained gels. All other proteins concentrations were assessed using the DC 
Protein Assay kit as per the manufacturer's instructions (Bio-Rad Laboratories, Mississauga, 
ON).  
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2.7 — Microscopy 
2.7.1 — Fluorescence Microscopy 
Acridine orange (AO) is a hydrophobic dye that is membrane permeable and intercalates 
DNA and RNA molecules. When excited by blue light, acridine orange emits a green light 
(525nm filter) when complexed with DNA. In an acidic environment, acridine orange is 
protonated and forms aggregates, shifting the emitted wavelength into the bright red light 
(620nm filter). Ethidium bromide (EtBr) is not membrane permeable but also intercalates DNA, 
and emits light in the red-orange range (595 nm). In cells co-stained with AO/EtBr, co-
localization of both dyes (yellow) will indicate cells having lost membrane integrity and can be 
presumed dead. Therefore, AO/EtBr staining can be used to reveal changes in cell morphology 
(such as the formation of apoptotic bodies) and to analyse the acidity of intracellular organelles, 
such as the lysosomes.   
For the analysis of the morphology of apoptotic cells, Sp2/0 cells were collected and 
placed on ice for 10 min, washed twice and stained for 1 min at room temperature in a staining 
buffer (acridine orange 6 µg/mL, ethidium bromide 6 µg/mL in PBS) and analyzed using a Leitz 
Diaplan microscope  (Leica Microsystems, Richmond Hill, ON).  
The presence of acidic vacuoles was assessed by AO staining using the 620nm filter by 
fluorescence microscopy. Sp2/0 cells were stained in culture at a final acridine orange 
concentration of 1mg/mL for 20 min (209). Cell culture was collected by pipette and washed 
twice in PBS, mixed with an equal volume of VectaShield Mounting Medium (Vector 
Laboratories Inc., Burlington, Ontario) before mounting the samples on slides. Images were 
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captured by a Zeiss Axiovert 200M fluorescence microscope with 546nm excitation and 590nm 
emission and analyzed using the Carl Zeiss AxioVision Axio VS40 software, version 4.5.0.0 
(210). Quantitation was done by assessing the percentage of brightly stained cells versus the 
overall number of cells counted across all captured fields. Brightly stained cells were defined as 
cell with intense colouring comparable to the indicated control condition.  
2.7.2 — Analysis of Mitochondrial Transmembrane Potential  
The mitochondrial transmembrane potential was assessed by confocal microscopy. 
Cultured Sp2/0 cells were stained in the dark at 37°C, 5% CO2 in a humidified atmosphere with 
Mitotracker Red CM-H2XRos (50nM, Invitrogen, Burlington ON.) 30 min prior to the end of 
treatments. Cells were collected, washed twice in PBS and fixed for 5 min at room temperature 
in 1mL of a 4% paraformaldehyde solution. Cells were washed twice in PBS and resuspended in 
equal volumes of an 80% glycerol solution. Images were captured using a Zeiss LSM 510 Meta 
confocal microscope (Carl Zeiss Canada, Toronto, ON) with an argon laser at 578nm absorbance 
and 599nm emission maxima, with 63X magnification and analyzed using Carl Zeiss Laser 
Scanning Microscope LMS 510 version 3.2 software. 
2.7.3 — Transmission Electron Microscopy 
Transmission electron microscopy (TEM) analysis was performed at the Electron 
Microscopy Laboratory, University of New Brunswick (Fredericton, NB). Cultured Sp2/0 cells 
(1x107) were collected, washed twice in PBS and fixed for 2-4h in 3% glutaraldehyde in 0.1 M 
sodium cacodylate buffer, pH 7.4.  After primary fixation the cells were washed in the same 
buffer twice and stored at 4°C before processing. Processing occurred as previously described 
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(211). Briefly, 1% (v/v) OsO4 post-fixed cells were dehydrated through a series of acetone 
washes. Samples were infiltrated with an Epon-Araldite resin/acetone mixture and embedded in 
resin in gelatin capsules and flat-embedding moulds. Sections (100nm) were collected onto 
uncoated copper grids, double stained with uranyl acetate and Teynolds lead citrate, and 
observed under a Philips 400T transmission electron microscope. Images were exposed onto 
negative film (Kodak Electron Microscope film 4489). 
2.8 — Statistical Analysis 
Statistical analyses were performed using paired t-test or one-way ANOVA with 
Scheffé's post hoc test, using the statistical software Analyse-it version 2.24 for Microsoft Excel 
2007. Statistical significance was assessed with a confidence of 95%. 
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3.0 — RESULTS 
3.1 — EFFECT OF GLUTAMINE LIMITATION ON CELL BEHAVIOUR 
Our research group has established that glutamine can affect Sp2/0 cell fate, at least in 
part by affecting mitochondrial function. Upon glutamine starvation, Sp2/0 cells rapidly undergo 
apoptosis via the intrinsic apoptotic cascade which is initiated at the mitochondria (53). The lack 
of available glutamine is accompanied by oxidative stress characterized by the accumulation of 
reactive oxygen species, protein carbonyl groups and a decrease in glutathione. The oxidative 
stress activates the p38 MAPK and is associated with the formation of apoptotic bodies, but not 
with the apoptosis induction (199, 200). Also, in a stationary batch culture system, GADD-153 
expression increases as the viability of Sp2/0 cells decreases, though supplementation of 
glutamine into the batch culture is sufficient to keep GADD-153 expression low, indicating that 
glutamine can modulate the expression of GADD-153 (212). Our research group has also shown 
that overexpression of the anti-apoptotic Bcl-2 family member Bcl-xL protects Sp2/0 cells: when 
overexpressed, Bcl-xL increases viability and decreased the dependence of Sp2/0 on glutamine, 
and delayed the expression of GADD-153, though it could not prevent GADD-153 expression in 
the later stages of batch culture (110, 197, 212). 
The demonstration by our research group that Gln deprivation triggers a rapid apoptotic 
response in Sp2/0 cells allowed us to raise the following questions: 1) Is there a critical threshold 
of Gln concentration required for the maintenance cell survival? 2) If so, are the biochemical 
apoptotic events triggered at Gln concentrations under this minimal threshold (i.e. limiting Gln 
concentrations) identical to those already described upon acute Gln starvation (where 
extracellular Gln is not available to the cells). 3) Finally, are other basic cellular processes, such 
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as proliferation, also regulated by this critical threshold of Gln concentrations, or do they require 
a different minimal concentration of the amino acid? The first part of my thesis aimed at 
providing some answers to these questions by evaluating the effects of glutamine limitation on 
cell behaviour, including cell survival, apoptosis and cell cycle progression. 
To address these questions, two experimental approaches were used. Firstly, the effect of 
different glutamine concentrations on the viability and proliferation of Sp2/0 cells was studied. 
Secondly, the effect of glutamine limitation was studied by exposing Sp2/0 cells to a limiting 
concentration of glutamine of 25 µM. Several parameters related to cell viability, death, 
proliferation were then examined. 
The reader will note that several of the figures shown in this chapter (specifically, Figs. 
3.4, 3.5, 3.7, 3.9, 3.11, 3.13 and 3.17) were originally published as part of the Master’s thesis of 
another student of the Gauthier laboratory (213). Figures 3.2 and 3.15 were contributed by Curtis 
C. Harnett. In consultation with my supervisor, I have chosen to include them here in order to 
provide context to my own contribution to this study.  
3.1.1 — Glutamine Limitation 
As a first step in characterizing the response of Sp2/0 cells to limiting amounts of 
glutamine, we cultured this cell line for 24h in the presence of a range of glutamine 
concentrations. The range of glutamine concentration was selected using previously unpublished 
data (213). It must be noted that this range includes the normal serum level of 0.5-0.7 mM found 
in humans (214).  
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We first examined the effect of glutamine concentration on the total number of cells 
(figure 3.1). At glutamine levels of 100 µM or less, the total cell number did not change 
significantly from the seeded concentration over the 24h period, indicating that the glutamine 
levels were insufficient to sustain an increase in cell number.   
 
Figure 3.1 - Glutamine Availability Modulates Cell Density 
Cells were cultured for 24h in medium supplemented with the indicated glutamine 
concentrations. Cell number was then determined using a trypan blue assay. Data 
are the average ± SD of three independent experiments. Statistical significance 
was assessed by one-way ANOVA with Scheffé's post hoc test, and * indicates 
p<0.05 compared to 1000 µM. 
When the glutamine concentration was greater than 100 µM, a progressive increase in the 
total cell number was observed. The results in figure 3.1 show that glutamine availability in the 


























In order to confirm the data obtained using the trypan blue assay, we used flow cytometry 
to assess the effect of glutamine availability on cell cycle progression. Figure 3.2 is a 
representative panel showing the effects of glutamine concentration on the distribution of cells in 
the cell cycle.  
 
Figure 3.2 - Glutamine Limitation Prevents Cell Cycle Progression 
Cells were cultured for 24h in the indicated glutamine concentrations before 
collection. Cells were then processed for propidium iodide staining and flow 
cytometry analysis. The x axis of these panels is the mean fluorescence intensity 
(MFI) of the signal received, and the y axis records the number of events that 
occur at that particular MFI. Data are representative of 3 independent 
experiments. Figure courtesy of CC Harnett. 
The 1000 µM panel depicts typical cell cycle distribution for the Sp2/0 cell line. The 
peak over 50 MFI represents the G0/G1 peak (1 copy of the diploid DNA content), the peak over 
100 MFI is the G2/M peak (2 copies of the diploid DNA content), and the region between the 
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two is the S phase (between 1 and 2 copies of the diploid DNA content). Cells found below the 
50 MFI peak are classified as sub-G1 and considered dead by virtue of containing less than the 
normal diploid DNA content.  When cells were cultured in medium containing less than 1000 
µM glutamine, we observed that the number of events decreased in the S and G2/M phases and 
increased in the G1 phase. A sub-G1 peak is also observed at glutamine concentrations under 50 
µM. These data indicate a decrease in proliferative capacity, likely due to a block in G1, and an 
increase in cell death after 24h of culture in glutamine limiting conditions.  
The next experiment was designed to assess whether a critical threshold of glutamine 
concentration was required for the maintenance of cell viability. Cells were seeded at a density of 
4x105 cells/mL in medium containing a range of glutamine concentrations, cultured for 24h, and 
the number of membrane-intact cells was determined using the trypan blue dye exclusion assay. 
As shown in figure 3.3, the percentage of viable cells decreased drastically when the glutamine 
concentration in the medium was below 100 µM.  
These results show that a concentration of glutamine of at least 100 µM in the culture 
medium is required to ensure optimal cell viability under our experimental conditions.  
To confirm the effect of Gln concentrations on cell viability, we first examined cell 
morphology. To this end, cells were stained with acridine orange and with ethidium bromide 
(figure 3.4, panel A). When cells were cultured in medium containing 1000 µM or 100 µM 
glutamine, the majority of cells stained green, had the circular shape expected from viable B 
cells (215) and excluded ethidium bromide, indicating that they have maintained membrane 
integrity. However, when the glutamine concentration in the medium was less than 100 µM (25 
µM and 8 µM), cells stained red (single stain) or yellow (colocalization of green and red), 
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indicating that they have lost their membrane integrity, they lost the regular circular shape, and 
demonstrated the characteristic "popcorn" shape of apoptotic cells (216).  
 
Figure 3.3 - Glutamine Concentration Affects Cell Viability 
Sp2/0 cells were cultured for 24h in indicated glutamine concentrations. The data 
are the average percentage of membrane intact cells ± standard deviation of 5 
independent experiments. Statistical significance was assessed by paired two-
tailed t-test, and all groups are statistically different from each other with a 
confidence of p<0.01. Statistical analysis by one-way ANOVA showed statistical 



































Figure 3.4 - Micromolar Levels of Glutamine Trigger Apoptosis 
Cells were cultured in medium supplemented with the indicated glutamine 
concentrations for 24h. A) Cells were stained with acridine orange (green) and 
ethidium bromide (red). The arrows show apoptotic cells. Panels are 
representatives of 3 independent experiments. B) Protein extracts were used in an 
in vitro caspase-3 peptide cleavage assay. Data is the average ± SD of 3 
independent experiments. Statistical analysis was done by one-way ANOVA with 
Scheffé's ad hoc test with * p<0.05 C) Picture of a Western blot performed on 
protein extracts using a PARP-1 antibody. Panel is representative of 3 
independent experiments; * indicates an unknown protein cross-reacting with the 
antibody. Figure courtesy of M. Mallory. 
One defining aspect of apoptosis is the activation of caspase-3, a protease playing an 
important role in the limited proteolysis of cellular proteins that in turn leads to the 
morphological changes characteristic of this type of cell death. The activity of caspase-3 was 
assayed using a colorimetric peptide cleavage assay. As shown in figure 3.4B, low caspase 
activity levels were measured in cells cultured in medium supplemented with 100 and 1000 µM 
!
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glutamine. This is consistent with our prior observations that the majority of the cells remain 
viable under these conditions (figure. 3.1). When available glutamine dropped below the 
threshold concentration of 100 µM, as shown in the 8 µM and 25 µM conditions, the level of 
caspase activity increased sharply. This was expected since we observed an abundance of 
apoptotic cells under these conditions (figure 3.4, panel A).  
Enzyme activity seen in vitro is not always translated in vivo. The next experiment was 
designed to assess whether in vivo markers for apoptosis were present under glutamine limiting 
conditions. PARP-1 was the first identified caspase target (217), has been reported to be cleaved 
in vivo by caspase-3/7 and PARP-1 cleavage is considered a hallmark of apoptosis (218). 
Proteins extracted from cells cultured for 24h in the indicated concentration of glutamine were 
processed for Western blot analysis, the results of which are presented in figure 3.4C. When the 
glutamine concentration is high (1000 µM), the full length 116 kDa form of PARP-1 was present 
with little to no presence of the 86 kDa cleaved form of PARP-1. The cleaved form appeared 
faintly in the 250 µM condition. This cleaved band became progressively more intense as the 
concentration of glutamine decreased and the full-length 116 kDa band concurrently became less 
intense. The 86 kDa band appeared in the same glutamine concentrations where the percentage 
of viable cells began to decrease (figure 3.1) suggesting an inverse dose-dependent relationship 
between glutamine concentration and PARP-1 cleavage.  
When the results of figures 3.1, 3.2 and 3.3 are examined jointly, they indicate that there 
is a threshold concentration of glutamine which modulates Sp2/0 cell behaviour. At 100 µM, 
cells are not proliferating, but viable. Below this concentration, cells are not viable and 
glutamine is limited for survival. Above this threshold, cells are viable and proliferating.  It 
should be noted that while there is no increase in cell density at 100 µM, it is possible that cells 
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have experienced a delay in proliferation that could have been detected at a later time point. 
However, this is unlikely without glutamine supplementation as Sp2/0 cells utilize glutamine 
rapidly and would likely exhaust the available glutamine and eventually undergo apoptosis. 
The morphology, loss of membrane integrity and in vitro and in vivo caspase-3 activity 
assays results presented in figure 3.4 are sufficient to support the conclusion that glutamine 
limitation triggers apoptotic cell death. 
3.1.2 — Glutamine Limitation and Starvation Trigger Distinct Signalling 
Pathways 
GADD-153 is transcription factor expressed in times of amino acid starvation, 
mitochondrial and endoplasmic reticulum stress (186, 219-222). GRP78 is a chaperone protein 
which contributes to the ER stress response and is co-expressed with GADD-153 in the unfolded 
protein stress response (223, 224) GADD-153 was previously shown to be upregulated under 
conditions of glutamine deprivation (188). To get a better understanding of the response elicited 
by glutamine limitation, Western blot analysis was used to determine the effect of glutamine 
concentration on the levels of GADD-153 and GRP78 (figure 3.5).  
There was no significant change in the levels of GRP-78 protein in glutamine limitation 
by Western blotting, suggesting that the cells did not undergo ER stress (figure 3.5). On the other 
hand, glutamine limitation caused a dramatic increase in GADD-153 levels. GADD-153 was 
expressed in a range of glutamine concentration of 0.004 to 250 µM. GADD-153 was not 
expressed when cells were cultured in medium which was not supplemented with glutamine, nor 
was it expressed when the culture medium contained glutamine at concentrations of 0.5 mM or 
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more. These findings indicated that, in Sp2/0 cells, the induction of GADD-153 requires the 
presence of a limited amount of glutamine. At higher glutamine concentrations, GADD-153 is 
repressed, in accordance with previous studies (188, 212, 213). On the other hand, a 24h 
glutamine starvation does not lead to GADD-153 expression. When cultured in medium not 
supplemented with glutamine, Sp2/0 cells would undergo apoptosis before the upregulation of 
GADD-153 could occur (53). Interestingly, the range of glutamine concentrations where GADD-
153 is expressed is also the range of concentrations of glutamine that have been previously 
shown to either limit proliferation or to lead to apoptosis (figures 3.1 to 3.4).  
 
Figure 3.5 - Glutamine Availability Modulates GADD-153 Expression 
Protein extracts from cells cultured for 24h in the indicated glutamine 
concentrations were processed for Western blot analysis and probed with the 
indicated antibodies. Data are representative of 3 independent experiments. Figure 
courtesy of M. Mallory. 
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Previous work from our laboratory has shown that, in Sp2/0 cells, apoptosis is triggered 
within 30 min of glutamine starvation, as measured by cytochrome c and SMAC release into the 
cytosol and caspase-3 activity (53). Therefore, we reasoned that the rapid cell death program 
triggered in these cells upon glutamine starvation may have prevented the initiation of a full 
stress response, including the induction of GADD-153 expression. If this were the case, then 
simply blocking the apoptotic program with a caspase inhibitor should restore the stress response 
and GADD-153 expression. To test this idea, Sp2/0 cells were cultured for 24h in medium not 
supplemented with glutamine (starvation group), in medium containing 25 µM glutamine 
(glutamine limited group), and in medium containing 4 mM glutamine (control). For each group, 
cells were either supplemented with the caspase inhibitor Z-VAD-fmk or an equivalent amount 
of DMSO. 
When Sp2/0 cells were cultured in medium deprived of glutamine, 4.77 % of the 
population retained their membrane integrity (figure 3.6). This was not statistically different in 
the DMSO-treated population, with 5.06 % of cells maintaining integrity. In the Z-VAD-fmk-
treated population, 33.75 % of cells were membrane intact. This was expected, since it had 
already been established that glutamine deprivation triggers caspase activation in Sp2/0 cells 
(53). 
When Sp2/0 cells were cultured in medium containing 25 µM glutamine, cell viability 
was considerably higher than in the glutamine-starved group. The proportion of viable cells in 
the Gln-limited and DMSO control was not significantly different: 36.02% in Sp2/0 cells, and 
34.32% in DMSO-treated cells. However, in the presence of Z-VAD-fmk, there was a significant 
increase in viability compared to the two control groups. Since Z-VAD-fmk is a pan-caspase 
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inhibitor, this finding was expected because of the observation of increased caspase-3 activation 
in cells cultured in medium containing 25 µM glutamine (figure 3.4B, C).  
There was no statistical difference between the treatment groups in the 1000 µM 
glutamine concentration.  
 
Figure 3.6 - The Additive Effect of Micromolar Glutamine Levels and 
Caspase Inhibition on Cell Viability  
Cells were cultured for 24h in the indicated concentrations of glutamine with or 
without 10 µM Z-VAD-fmk or the equivalent amount of DMSO. Cells were then 
counted by trypan blue exclusion assay. Data represents the average ± SD of 3 
independent experiments. * Statistical significance of p<0.01 by one-way 
ANOVA with Scheffé's post hoc test. Pale gray are untreated cells, dark grey are 


































These results indicated that caspase inhibition in conjunction with a micromolar 
concentration of glutamine had an additive protective effect and that the protective effect 
afforded by caspase inhibition alone in glutamine deprivation was similar to that afforded by the 
25 µM glutamine concentration. Our previous results (figure 3.5) showed that GADD-153 was 
expressed at the 25 µM glutamine concentration, and so we investigated whether caspase 
inhibition would have any effect on the expression of GADD-153. 
As shown in figure 3.7 and consistent with the results in figure 3.5, there was little to no 
expression of GADD-153 without glutamine supplementation of the culture medium or in the 
1000 µM glutamine condition, irrespective of whether DMSO or with Z-VAD-fmk had been 
added to the culture.  
 
Figure 3.7 - Caspase Inhibition Does Not Influence GADD-153 Expression 
Following Glutamine Limitation 
Western blot analysis performed on protein extracts from cells cultured for 24h in 
medium containing the indicated glutamine concentrations. Data is representative 
of 3 independent experiments. Figure courtesy of M. Mallory. 
Again in line with results shown in figure 3.5, GADD-153 is expressed in the 25 µM 
glutamine group treated with DMSO. Interestingly, it is also present in the 25 µM glutamine 
condition supplemented with Z-VAD-fmk but with no marked increase in intensity when 
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compared to the corresponding DMSO control. This suggests that caspases are not important for 
the induction of GADD-153 expression and, by extension, for the stress response triggered in 
glutamine-starved/limited cells. 
The loss of mitochondrial integrity is a major event in several apoptotic pathways, and is 
subject to regulation by the balance of pro- and anti-apoptotic proteins of the Bcl-2 family (225). 
Our research group has previously shown that Sp2/0 cells have few anti-apoptotic Bcl-2 family 
members, with Mcl-1 being expressed at the highest level (figure 1.8). Moreover, the 
overexpression of the Bcl-2 family member Bcl-xL is sufficient to significantly protect 
glutamine-starved Sp2/0 cells against the induction of apoptosis (110, 197). We next designed 
experiments to assess the effect of Bcl-xL overexpression in the stress response triggered by 
glutamine limitation in Sp2/0 cells.  
As shown in figure 3.8, ectopic Bcl-xL expression is sufficient to protect Sp2/0 cells 
against cell death caused by glutamine limitation or starvation. In conditions of glutamine 
deprivation, the control group transfected with the pTEJ8 vector had a proportion of cells with 
intact membranes of 2.6%, while for the cells transfected with Bcl-xL, this proportion rose to 
33.0%. When transfected cells were cultured in medium containing 25 µM of glutamine, 
viability was significantly increased in both cases: the percentage of viable cells was 32.34% for 
pTEJ8-transfected cells and 68.83% for Bcl-xL-transfected cells. Interestingly, there was no 
statistically significant difference in cell viability between glutamine-deprived Sp2/0 
overexpressing Bcl-xL and Sp2/0 cells containing the vector control and cultured under 
glutamine -limited conditions.  
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Figure 3.8 - Bcl-XL Overexpression and Micromolar Amounts of Glutamine 
Have an Additive Protective Effect 
Sp2/0 cells transfected with either the empty vector pTEJ8 or with the vector 
containing a cDNA encoding Bcl-xL were cultured for 24h in medium containing 
the indicated concentrations of glutamine (111). Cells were then counted by 
trypan blue exclusion assay. Data represents the average ± SD of 3 independent 
experiments. Statistical significance (p<0.05 one-way ANOVA with Scheffé's 
post hoc test) is indicated by the following symbols for paired concentrations: * 
pTEJ8 0 mM glutamine vs Bcl-xL 0 mM glutamine, ¶ pTEJ8 25 µM glutamine vs 
Bcl-xL 25 µM glutamine. The pTEJ8 cells are pale grey and the Bcl-xL are in 
black.  
Protein extracts for each treatment group were analyzed for GADD-153 expression by 
Western blotting, as shown in figure 3.9. As expected in light of the results presented in figures 
3.5 and 3.7, GADD-153 expression was observed in the vector-control Sp2/0 cells cultured in 
medium containing 25 µM glutamine. Interestingly, GADD-153 expression was detected in both 


































Bcl-xL is an anti-apoptotic member of the Bcl-2 family of protein that interacts with pro-
apoptotic Bcl-2 family members to prevent the formation of pores on the mitochondrial outer 
membrane. Its presence would serve to prevent the release of cytochrome c and SMAC/Diablo 
from the mitochondria, preventing intrinsic apoptotic pathway activation (102, 202, 225). The 
presence of a GADD-153 signal in the glutamine-deprived cells transfected with Bcl-xL confirms 
our previous data indicating that mitochondrial integrity is important to the stress response 
triggered by glutamine limitation (35).  
 
Figure 3.9 - Increased GADD-153 Expression in Glutamine-Deprived Bcl-XL-
Transfected Cells 
Western blot analysis performed on protein extracts from cells cultured for 24h in 
medium containing the indicated glutamine concentrations. Anti-HSP60 was used 
as loading control. Data are representative of 3 independent experiments. Figure 
courtesy of M. Mallory. 
The results presented thus far indicate that the restriction of glutamine in the culture 
medium affects cells viability and proliferation in a dose-dependent manner at 24h and that the 
cells that were not viable underwent apoptosis. During that same time period, a stress response to 
glutamine limitation was induced, as revealed by the induction of the expression of GADD-153. 
Additionally, while caspase inhibition in glutamine-starved Sp2/0 cells could increase the 
number of viable cells to the same amount seen in the glutamine-limited culture, it had no effect 
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on GADD-153 expression. Finally, Bcl-xL overexpression did have an effect on GADD-153 
expression, allowing for its expression in glutamine-deprived conditions and implicating the 
mitochondria in the stress response triggered by glutamine limitation in Sp2/0 cells.  
3.1.3 — Chronology of Responses to Glutamine Limitation  
The data shown so far indicate that a stress response was initiated upon glutamine 
limitation in Sp2/0 cells. Moreover, this stress response is not seen in glutamine-starved Sp2/0 
cells, indicating that a minimal threshold of glutamine is required. Since all of the previous 
studies were performed at 24h endpoint, we set out to expand our investigation of this 
phenomenon by performing time-course experiments in which GADD-153 expression as well as 
various apoptotic markers were examined.  
For these experiments, we chose a glutamine concentration of 25 µM because at that 
concentration, GADD-153 was highly expressed (figure 3.5) and a significant proportion of the 
cell population was still viable after 24h of culture. This indicated that at that concentration, the 
stress response had been initiated and had partially succeeded in protecting some cells from 
apoptotic cell death. The first experiment we devised was to establish the amount of time for 
which the Sp2/0 cell population could be exposed to 25 µM of glutamine before the activation of 
the apoptotic death program. Sp2/0 cells cultured for 24h in limiting glutamine concentrations 
die by apoptosis (figure 3.4). In order to establish the time frame required for the commitment to 
the death program, Sp2/0 cells were cultured in medium containing 25 µM for set time intervals 
before the culture medium was supplemented with 4 mM of glutamine. The cells were returned 
to culture for the remainder of the 24h period then viability was assessed by a trypan blue assay. 
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The percentage of dead cells at 24h is taken as an estimate of the percentage of cells committed 
to the death program, at the time of glutamine supplementation.  
As shown in figure 3.10, after 4h of culture in 25 µM concentration of glutamine, a 
progressive increase in the number of non-viable cells was observed, with 19.9% at 8h, 28.0% at 
12h, and 65. 9% at 24h. The 4 mM glutamine treatment group was included as a control: as 
expected, less than 10% of cells in culture (7.1%) had lost their membrane integrity. Even after 
12h in culture, the viability of the majority of the cell population could still be rescued. By 
comparison, 79.6 % of the cells in the control treatment group consisting of cells starved of 
glutamine for 4h had lost their membrane integrity and is in line with earlier observations made 
by our research team (53).  
It had been previously established that glutamine deprivation triggers cell death via the 
intrinsic apoptotic pathway (53). We sought to characterize the biochemical events leading to 
apoptosis in cells cultured in medium containing a limiting amount of glutamine. In several 
apoptotic pathways, executioner caspases (such as caspase-3) are activated by cleavage by 
initiator caspases (such as caspase-9) (202, 218, 225).  
We first analysed caspase-3 activation. Protein extracts from Sp2/0 cells that were 
cultured in medium containing 25 µM over a 24h period were probed for the presence of the 
activated, cleaved form of caspase-3 (figure 3.11). The cleaved form of the protein was detected 
at the 4h time point, but unexpectedly it was not apparent at the 8h time point. The cleaved form 
of caspase-3 was not detected again in protein extracts until the 24h time point. The levels of the 
HSP60 control were constant, indicating that the absence of the cleaved caspase-3 protein at the 
8 and 12h time points was not the result of improper sample loading of the gel.  
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Figure 3.10 - Micromolar Levels of Glutamine Protects Cells From Cell 
Death  
Sp2/0 cells were cultured in 25 µM glutamine for the indicated length of time 
before the glutamine was adjusted to 4 mM. Cells were counted by trypan blue 
exclusion assay 24h after the start of the experiment. Data represents the average 
± SD of 3 independent experiments. Statistical significance (vs T = 0h) was 
assessed by ANOVA + Scheffé's ad hoc test with * p<0.05. 
While the cleaved form of caspase-3 has been reported to be the active form of the 
enzyme, we sought to confirm these results by performing a caspase-3 colorimetric activity 
assay. Sp2/0 cells were cultured in medium containing 25 µM glutamine over a 24h period and 
protein extracts were prepared and subjected to an in vitro synthetic peptide cleavage assay. The 
results obtained are shown in figure 3.12. In accordance with previous results (figure 3.5), there 
was little cleavage of the DEVD peptide in the extracts from cells cultured in medium containing 
1000 µM glutamine. We observed a statistically significant increase in caspase-3 activity after 4h 
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of culture in medium supplemented with 25 µM glutamine. Interestingly, there was a statistically 
significant decrease in caspase-3 activity after 8h in culture when compared to the 4h time point. 
Caspase-3 activity remained low for several hours, and was statistically significantly increased at 
the 24h time point, where the greatest amount of caspase-3 activity was measured. These results 
confirmed the findings presented in figure 3.11. 
 
Figure 3.11 - Effect of Micromolar Glutamine Levels on Caspase-3 Cleavage 
Western blot analysis of protein extracts from cells cultured over a period of 24h 
in medium containing 25 µM glutamine and probed with an anti-caspase-3 
antibody recognizing the cleaved form of the protease. An anti-HSP60 antibody 
was used as a loading control. Data are representative of 3 independent 
experiments. Figure courtesy of M. Mallory. 
The in vitro activity assay results were confirmed in vivo by the analysis of PARP 
cleavage. In figure 3.13, it can be observed that the cleaved form (85 kDa) of PARP-1 was 
absent at the beginning of the time course (0h) and in the 1000 µM glutamine condition which is 
consistent with the low activity of caspase-3 in these samples (figures 3.4, 3.11 and 3.12). The 85 
kDa cleavage product was observed at the 4h time point. Interestingly, the intensity of the signal 
neither increased nor disappeared at the 8h or 12h time points, suggesting that little or no further 
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cleavage of PARP-1had occurred. A more intense cleaved PARP band was finally seen after 24h, 
in agreement with a much higher caspase-3 activity in this sample.  
 
Figure 3.12 - Micromolar Levels of Glutamine Affect Caspase-3 Activity 
Protein extracts were used in an in vitro caspase-3 peptide cleavage assay. Data 
are the average ± SD of 3 independent experiments. Statistical analysis was done 
by one-way ANOVA with Scheffé's ad hoc test with * p<0.01 compared to T=0h 
and ¶ p<0.05 compared to T=4h.  
Figures 3.11 to 3.13 clearly show that caspase-3 is not only in its cleaved form, active 
both in vitro and in vivo at the 4h time point, but that the activity is decreased at 8h. In the 
glutamine deprivation model, caspase-3 activation was induced as early as 30 min after 
glutamine withdrawal, and inevitably led to cell death by apoptosis by 4h (53). These results 




















the onset of death. Alternatively, these results may indicate that there is a subset of the 
population that is more sensitive to the limited amounts of glutamine present in the culture 
medium and undergo apoptosis within 4h. In this scenario, the rest of the population would not 
be affected until approximately 12h in culture. 
 
Figure 3.13 - Micromolar Glutamine Levels Delay the Onset of PARP-1 
Cleavage  
Western blot analysis of protein extracts from cells cultured over a period of 24h 
in medium containing 25 µM glutamine, and probed with anti-PARP-1 antibody 
recognizing both the cleaved and uncleaved forms of PARP-1. An Anti-HSP60 
antibody was used to control for gel loading. Data are representative of 3 
independent experiments. The star (*) indicates an unknown protein which cross-
reacted with the PARP antibody. Data are representative of 3 independent 
experiments. Figure courtesy of M. Mallory. 
Work previously done by our research team demonstrated that the intrinsic apoptotic 
pathway was triggered rapidly in glutamine-deprived Sp2/0 cells (53). We therefore set out to 
determine whether the induction of apoptosis under glutamine limiting conditions also involves 
the intrinsic pathway. The first assay performed was to assess the activity of caspase-9, the 
initiator caspase of the intrinsic pathway (225). 
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As shown in figure 3.14, there was no detectable increase in caspase-9 activity in the first 
12h of culture in 25 µM glutamine. In fact, caspase-9 activation was only detected after 24h of 
culture, when the majority of Sp2/0 cells were not viable (figure 3.1). Since the caspase-9 
activity assay did not provide any insight into the method of apoptosis activation, we assayed 
other indicators of apoptosis.  
 
Figure 3.14 - Caspase-9 Is Not Active Early in the Stress Response  
Protein extracts from Sp2/0 cells cultured over 24h in 25 µM glutamine were used 
in an in vitro caspase-9 fluorometric peptide cleavage assay. Data are the average 
± SD of 3 independent experiments. 
One of the upstream events leading to activation of caspase-3 in the intrinsic pathway is 
the release of cytochrome c from mitochondrial intermembrane space when the mitochondrial 






















caspase-9 via the formation of the apoptosome (53, 225). To determine the kinetics of 
cytochrome c release from the intermembrane space, cytosolic proteins were extracted from cells 
cultured for the indicated time intervals in medium containing 25 µM of glutamine, and 
subjected to Western blotting analysis.  
Representative results from these analyses are shown in figure 3.15. There was little 
cytochrome c in the cytosol at the beginning of the assay, consistent with the low percentage of 
dead cells in the culture at this point (figures 3.10, 3.12-14). However, there was an appreciable 
increase in cytosolic cytochrome c at 4h followed by a decrease to baseline levels at 8h. This 
coincides with the activation profile of caspase-3 during the first 8h of cell culture in glutamine-
limiting medium (figures 3.11-12). Interestingly, the levels of cytosolic cytochrome c rose again 
at 12h and 24h, results consistent with the activation of caspase-9 (figure 3.14).  
 
Figure 3.15 - Effect of Micromolar Glutamine Concentrations on the 
Cytosolic Release of Cytochrome C 
Western blot analysis of cytosolic protein extracts from Sp2/0 cells cultured over 
a period of 24h in medium containing 25 µM glutamine and probed with an anti-
cytochrome c antibody. An anti-PTEN antibody was used as loading control. Data 
are representative of 3 independent experiments. Figure courtesy of CC Harnett. 
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Because cytochrome c was leaking from the mitochondrial outer membrane, the 
mitochondrial transmembrane potential was assessed (figure 3.16).  
 
Figure 3.16 - Effect of Glutamine Limitation on the Mitochondrial 
Transmembrane Potential  
Confocal microscopy pictures of cells cultured for 4h in medium containing 
varying concentrations of glutamine and stained with Mitotracker H2ROS Red. a) 
1000 µM glutamine, b) 0 mM glutamine, c) 25 µM glutamine. Data are 
representative of 3 independent experiments with on average 25 cells for each 
sample. Magnification = 630 x. Micrographs taken at lower magnification and 
showing clusters of cells can be found in Appendix A.1. 
After 4h, cells that were cultured in medium containing 1000 µM glutamine were round 
in shape and had bright MitoTracker Red CM-H2XRos staining (figure 3.16, panel A), indicating 
that they possessed healthy mitochondria that are capable of oxidizing the reduced dye. When 
Sp2/0 cells were deprived of glutamine for 4h, cells were noticeably smaller and were faintly 
stained with the Mitotracker dye (figure 3.16b). This was expected because previous work from 
our laboratory showed that Sp2/0 cells exhibit cytochrome c leakage as early as 1h after 
glutamine deprivation (53). However, as seen in Figure 3.16c, cells cultured for 4h in 25 µM 
glutamine had morphology and Mitotracker staining similar to those found in cells cultured in 
medium containing 1000 µM glutamine. This indicates that micromolar amounts of glutamine 
are sufficient for cells to maintain their mitochondrial membrane potential for several hours. The 
majority of cells at 4h in 25 µM glutamine maintained their mitochondrial membrane potential as 
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assessed by Mitotracker Red; considering that caspase-9 and caspase-3 were not highly active at 
and that the cells were viable at this point, this was to be expected.  
Our previous results demonstrated that the induction of GADD-153 expression in Sp2/0 
cells only occurs when the glutamine concentration in the culture medium is limiting (figures 
3.5, 3.7 and 3.9). To better understand the dynamics of the stress response, GADD-153 
expression was evaluated in the 24h time course. As shown in figure 3.17, GADD-153 was first 
expressed after 4h in culture in medium containing 25 µM of glutamine, and its expression 
increased over time, with the most intense expression at 24h. GADD-153 expression paralleled 
the increase in caspase-3 activation (figure 3.12) and the decrease in cell viability (figure 3.10). It 
is interesting to note that the late increase in caspase-3 activity coincided with the time when 
GADD-153 was most intense.  
 
Figure 3.17 - Micromolar Amounts of Glutamine Affect GADD-153 
Expression  
Western blot analysis of protein extracts from Sp2/0 cells cultured over a period 
of 24h in medium containing 25 µM of glutamine. HSP60 was used as loading 
control. Data are representative of 3 independent experiments. Figure courtesy of 
M. Mallory. 
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3.1.4 — Distribution in the Cell Cycle 
One interpretation of the data shown so far is that there are two separate populations in 
the culture, which could be distinguished by the caspase-3 activation profile when cultured in 
medium containing 25 µM glutamine: those with active caspase-3 at 4h and those with caspase 
activity at 12h. The next series of experiments were designed to assess whether two such 
populations existed. The first aspect that was considered was whether there were variants within 
the Sp2/0 cell population which could account for the differences in caspase activation (figure 
3.18). 
In order make that evaluation, clonal populations of Sp2/0 cells were obtained by limiting 
dilution and propagated. Each clonal population (A5, B1, B3, B4 and B5) with the parental line 
(AC1) were cultured for 24h in medium supplemented with 25 µM glutamine, rescued by 4 mM 
glutamine supplementation at the indicated time interval, and the commitment to death assessed 
by trypan blue exclusion assay as described previously. The results clearly show that there was 
no difference in the behaviour of the parental line and any of the clones. Thus, the presence of 
clonal variants in our original culture does not account for the biphasic induction of apoptosis 
observed in Sp2/0 cell cultured under conditions of glutamine limitation.  
Interestingly, restriction of glutamine has been proposed recently to function as a 
metabolic checkpoint preventing cell cycle progression (226). Therefore, we assessed another 
possibility: that progression through a particular phase of the cell cycle could render the Sp2/0 
more vulnerable to apoptotic cell death when cultured under limiting glutamine conditions. 
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Figure 3.18 - Commitment to Death Is Not an Artefact of Clonal Selection 
Cells were cultured in culture medium containing 25 µM glutamine for the 
indicated period of time before 4 mM glutamine was added to the medium. Mean 
percentage of cells not committed to death after culture at 400 000cells/mL in 
25uMQ, with 4 mM Q added in at specified times. The AC1 is the parental line to 
which all clones (A5, B1, B3, B4 and B5) are compared. Average of three 
independent trypan blue exclusion assays. 
In order to assess this possibility, cells cultured in medium containing 25 µM glutamine 
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distribution analysis. As shown in figure 3.19, the percentage of cells in sub-G1 increased 
progressively over time reaching 21.36% after 24h of culture in medium containing 25 µM 
glutamine. The percentage of cells in sub-G1 at each of the time points after the start of culture is 
statistically distinct from the baseline (0h). The percentage of cells in sub-G1 in the culture 
control condition, 24h in the presence of 4 mM glutamine, is not statistically distinct from the 
baseline value. 
 
Figure 3.19 - Effect of Micromolar Glutamine on Cell Cycle Distribution  
Sp2/0 cells were cultured in medium containing 25 µM glutamine over a period of 
24h. Cells were collected at the indicated time points and processed for propidium 
iodide staining and flow cytometry analysis. Data represent the average ± SD of 3 
independent experiments. Statistical significance was assessed by paired t-test 
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At baseline, 29.28% of cells were in the G0/G1 phase, 32.86% at 4h, 34.74% at 8h and 
32.05% at 24h. In the culture control condition, the proportion of cells in the G0/G1 phase is 
42.31%. Only the culture control condition is statistically different from the baseline value, 
indicating that accumulation occurs only in this condition. 
Cells that are proliferating will be found in the S phase and progressing into the G2/M 
phase. For the S phase, 26.36% of cells are in this phase at baseline, with 32.00% at 4h, 26.58% 
at 8h and 20.17% at 24h. The difference is statistically significant at 24h compared to baseline 
and, when compared to the 4h time point, both the 8h and 24h percentages are statistically 
different. This difference is also observed when comparing the 24h time point to the 8h time 
point. The conclusion to be drawn is that after 4h of culture in medium containing 25 µM 
glutamine, fewer cells are progressing into the cell cycle.  
For the G2/M phase, 24.43% of cells are in this phase at baseline, 22.24% at 4h, 25.19% 
at 8h and 10.83% at 24h. The change at 24h is statistically different from the baseline, the 4h and 
the 8h time point values. The peak in cell proportion is observed at the 8h time point before a 
sharp decrease at 24h. Interestingly, the difference in the percentage of cells between the 8h and 
the 24h time point, 14.81%, is very similar to the difference between the same time points in sub-
G1, 16.17%.  
The data presented in figure 3.19 shows that the proportion of cells in sub-G1 peak 
gradually increased over the course of the 24h period. This was not surprising as our results 
indicated that cell viability was slowly decreasing over the 24h period when cultured in medium 
containing 25 µM of glutamine. While this steady increase in sub-G1 was occurring, concurrent 
decreases were observed in the proportion of cells in both S and G2/M phases; on the other hand, 
 79!
the proportion of cells in G0/G1 was stable. These data suggest that the induction of apoptosis in 
cells cultured in the presence of 25 µM glutamine occurs preferentially in the cell population in S 
and G2/M phases. It should be noted that it is possible that cells may also be completing the cell 
cycle through G2/M to G1 before undergoing apoptosis. 
In order to test that hypothesis, several experiments were designed to assess which 
segment of the cell population was responsible for the increase in the sub-G1 phase. The first 
were designed to attempt to synchronize the Sp2/0 cells. This would facilitate the identification 
of a cell cycle phase in which cells would be more susceptible to undergo apoptosis under stress 
due to glutamine limitation. Since the Sp2/0 cell line is very sensitive to toxic insults (53, 197, 
200, 211), synchronization techniques which did not require the use cell cycle-interfering 
chemicals were chosen.  
The first cell cycle synchronization procedure we chose was growth factor starvation. 
Preliminary work done by our research group had shown that, while serum withdrawal led to 
apoptotic cell death, Sp2/0 cells cultured in medium containing 4 mM glutamine and 0.1% serum 
stopped proliferating but remained viable for at least 24h.  
As presented in figure 3.20, after 24h of culture in medium containing 1% serum and 4 
mM glutamine (panel A), cells progressed through the cell cycle as expected and did not 
synchronize. Many different serum concentrations were assayed, as well as different culture 
times. A range of serum concentrations from 0.1% to 1% in medium containing 4 mM of 
glutamine were trialed with no accumulation in G0/G1 (not shown). The most promising 
experimental conditions, 48h culture in medium containing 4 mM of glutamine and 0.1% serum, 
did present an accumulation of cells in the G0/G1, had few cells in the S and G2/M phase with 
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some cells in sub G0 (figure 3.20b). However, when released from the synchronizing pressure by 
a return to normal culture conditions (5% serum/4 mM glutamine) for 24h (figure 3.20, panel C), 
a high proportion of cells in sub-G1 was seen, making this experimental approach impractical. 
Serum starvation over 24h did not yield a synchronized population. 
 
Figure 3.20 - Cell Synchronization by Serum Starvation 
Sp2/0 cells were cultured in the indicated conditions for the indicated length of 
time before collection and subsequent EtOH fixation. Cellular DNA content was 
stained with propidium iodide and analysed by flow cytometry. Panel A: 24h 1% 
serum, panel B: 48h 0.1% serum and panel C: 48h 0.1% serum + 24h 5% serum.  
Gating identification: the sub-G1 peak: A (1.7%), I (23.6%), M (29.1%), the 
G0/G1 peak: B (37.2%), J (37.5%), N (29.7%), the S phase peak: C (32.8%), 
K(12.5%), O (10.6%) and the G2/M peak: D (17.7%), L (14.9%), P (10.7%). 
We next tested centrifugal elutriation as a means to obtain synchronized cell cultures. 
Elutriation is a technique based on the principles of sedimentation to separate objects according 
to their size. Cells in a typical Sp2/0 culture can be found to be in every phase of the cell cycle; 
these cells have different physical sizes due to the increase in mass when cells enter the cell 
cycle in G1, the differences in their DNA content as the genome is replicated in S phase and 
whether the two daughter cells have separated at the end of the G2/M phase.  
In centrifugal elutriation, there are two key pieces: the centrifuge to establish the 
centrifugal force and the counter flow going through the chamber (figure 3.21). The centrifuge is 
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run at a steady speed and the cells enter through the elutriation chamber with a counter flow of 
medium and form a gradient: the heaviest cells pellet, and the lightest cells are maintained in 
suspension by the current of the counter flow. By steadily increasing the counter flow rate, 
different segments of the population can be removed from the chamber and collected in fractions 
(227). In Figure 3.21, the white outlined cells would be collected in the first fractions, then by 
increasing the speed, the grey cells would be collected next, and the black-outlined cells would 
be collected last, if at all.  
 
Figure 3.21 - Illustration of Centrifugal Elutriation Principle 
The chamber is subjected to centrifugation which allows the cells coming into the 
chamber through the counter flow to form a gradient and/or pellet (black outline). 
The speed at which the counter flow is run through the chamber will remove cells 
according to their differences in mass, first the white-outlined black cells, then the 
gray cells.  
Using this technique, I was successful in purifying Sp2/0 cells residing in the G0/G1 
phase of the cell cycle, and the result is presented in figure 3.22. When a culture of Sp2/0 cells in 
the exponential growth phase was subjected to separation by centrifugal elutriation at a speed of 
1800 RPM with a counter flow rate of 7mL/min, 72.07% of cells were found in the G0/G1 peak, 
with 8.98% in the S phase, 6.93% in the G2/M phase and only 7.43% in the sub-G1 phase. This 
indicated that centrifugal elutriation could be used as a means to enrich an Sp2/0 population for 




limitation. Unfortunately, the experiment could not be performed due to mechanical failure of 
the centrifugal elutriator and the difficulty in obtaining replacement parts. 
 
Figure 3.22 - Cell Synchronization by Elutriation 
Sp2/0 cells were separated by elutriation at a centrifugal speed of 1800RPM with a 
flow rate of 7mL/min. A 50mL fraction was collected and processed for 
propidium iodide and flow cytometry analysis. Gate A; sub-G1 peak 7.4%, Gate 
B: G0/G1 peak 72.1%, Gate C: S phase peak 9.0% and Gate D: G2/M peak 6.9%. 
3.1.5 — Chapter Summary 
The results obtained thus far have shown that variations in glutamine concentration can 
affect cell behaviour.  
The results obtained in section 3.1.1have demonstrated that, under our experimental 
conditions, there is a threshold concentration of glutamine of 100 µM. Above this threshold, cells 
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survive and proliferate. At this threshold concentration, cells survive but cannot proliferate and 
below this threshold, cells die by apoptosis. The results have also demonstrated that a stress 
response is present: not all cells are dead in micromolar concentrations of glutamine. This stress 
response may be mediated by GADD-153, which is expressed only when glutamine is limiting; 
in the absence or abundance of glutamine, GADD-153 is not expressed. The presence of 25 µM 
of glutamine afforded Sp2/0 cells a measure of protection against apoptosis that was comparable 
to that afforded by ectopic expression of Bcl-xL or caspase inhibition. Ectopic expression of Bcl-
xL, but not caspase inhibition, allowed GADD-153 expression in glutamine-deprived conditions. 
Bcl-xL is involved in the negative regulation of both apoptosis and autophagy: it prevents the 
loss of MOMP in the former, and binds Beclin-1 to prevent autophagic initiation in the latter 
(202). Glutamine withdrawal leads to oxidative stress (199), a stress which is known to induce 
the expression of GADD-153 (228, 229). It is likely that apoptosis occurs too rapidly in Sp2/0 
deprived of glutamine for de novo synthesis of GADD-153 to occur without Bcl-xL expression, 
which affords Sp2/0 a measure of protection (figure 3.8). If this is the case, a study of GADD-
153 mRNA expression in Sp2/0 cells deprived of glutamine would address this question. The 
functional requirement for GADD-153 could also be assessed by performing RNA knockdown 
experiments or by generating GADD-153 knockout Sp2/0, then assessing the ability of Sp2/0 
cells of adapting to glutamine limitation. 
In section 3.1.2, a sequence of events was established. The majority of Sp2/0 cells 
cultured in medium containing 25 µM of glutamine were not irreversibly committed to the 
apoptotic program until 24h. Even at 12h, only 28.0% of cells had committed to the death 
program. However, there were two distinct populations: the first population entered into the 
apoptotic program at 4h in culture in medium containing 25 µM of glutamine as characterized by 
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caspase-3 activity, cytochrome c release and PARP-1 cleavage. The second population did not 
readily undergo apoptosis upon exposure to glutamine limitation. This second population likely 
comprises the cells expressing GADD-153 and showing intact mitochondrial potential. This 
could be identified by immunofluorescence experiments showing co-localization of GADD-153 
and membrane potential. As the stress of glutamine limitation continued, the cells eventually 
succumbed to apoptosis. Reports have shown that mitochondria regulate the expression of 
GADD-153 when reactive oxygen species levels in the mitochondria rise, a phenomenon that 
was associated with apoptosis in adipocyte and leukemia cell lines (228, 229).  
Section 3.1.3 presented results showing that, in Sp2/0 cells grown under conditions of 
glutamine limitation, there was a progressive increase in cells in the sub-G1 phase and a 
concomitant decrease in the proportion of cells in S and G2/M phase. These intriguing results led 
me to undertake further studies to try and come up with a potential mechanism that could 
responsible for the observations. These studies are described in sections 3.2 and 3.3 of my thesis. 
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CHAPTER 3.2 — AUTOPHAGY IN THE SP2/0 MODEL 
The results of section 3.1 led to the conclusion that the presence of micromolar 
concentrations of glutamine in the culture medium affected cellular signalling pathways and 
changed cellular fate. Even after 24h, a greater proportion of cells remained viable (figure 3.1) 
when compared to a 4-hour acute glutamine deprivation treatment (53). 
This increase in the number of viable cells in culture suggested that some cells may be 
able to adapt to the stress of limiting nutrients while awaiting more favourable conditions. As 
expected, inhibition of caspases provided some rescue from death since cells died by apoptosis, 
but this inhibition was not sufficient to rescue the majority of cells. Also, ectopic expression of 
Bcl-xL in conjunction with micromolar amounts of glutamine was sufficient to rescue the 
majority of cells from apoptotic death. Bcl-xL acts at the mitochondria to prevent pro-apoptotic 
Bcl-2 family members from creating pores in the outer mitochondrial membrane, a key step of 
the intrinsic apoptotic pathway (230). Interestingly, Bcl-xL can also block autophagy (202). 
These results raised the interesting possibility that both glutamine and Bcl-2 family 
members were involved in an “adaptation” response, blocking key steps of the apoptosis 
machinery and allowing for the onset of stress-related signalling. In that regard, our results also 
indicated that during the 24h period when the Sp2/0 cells were adapting to that stress, GADD-
153 was being expressed. There is one stress adaption response that has been linked to amino 
acid deprivation, GADD-153 and Bcl-2 family members: that response is autophagy (196, 202, 
231). 
Autophagy has not previously been characterized in the Sp2/0 model in the context of 
glutamine deprivation, though it has been reported in rapidly dividing cells such as those of 
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immune lineage, and is important to immune cell function, proliferation and development (232-
237). As such, I hypothesized that autophagy would be occurring in the Sp2/0 cell line and that 
the autophagic response would be modulated under conditions of glutamine limitation.  
3.2.1 — Visualisation of Acidic Organelles by Acridine Orange Staining 
Autophagy is characterized by the presence of acidic vacuoles that occur when lysosomes 
fuse with autophagosomes to form autophagolysosomes. This is an important step in autophagy; 
the formation of autophagolysosomes allows for the degradation of the contents of the vacuole 
into smaller building blocks that can be exported to the cytosol and recycled into different 
macromolecules without the requirement for de novo synthesis (238, 239). These acidic vacuoles 
can be visualized by the use of pH-dependent dyes such as acridine orange (AO). In low pH 
conditions, AO becomes protonated and loses its membrane permeability and thus becomes 
sequestered into acidic vacuoles (240).  
It should be noted that Sp2/0 cells are murine lymphoid cells; when compared to 
epithelial cells, lymphoid cells are characterized by a relatively small size, a large nucleus and 
small cytosol. Figure 3.23 illustrates the differential staining patterns of AO in Sp2/0 cells; the 
green AO staining visualized by the FITC filter was centralized and limited to the large nucleus 
while the orange staining visualized by the rhodamine filter clearly labelled different structures 
which resided in the cytosol. These data confirm that the AO staining procedure can be used in 
Sp2/0 cells to visualize acidic cytosolic organelles.  
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Figure 3.23 - Differential Acridine Orange Staining in Sp2/0 Cells 
Representative panel of AO staining in exponentially growing Sp2/0 cells. The 
image was captured by fluorescence microscopy at 40X magnification using the 
rhodamine filters on the left (orange, acidic staining) or the FITC filters on the 
right (green, nuclear staining). The arrows indicate cells which illustrate a 
differential AO staining obtained with the rhodamine and FITC filters, where the 
staining are not superimposed. 
3.2.2 — Glutamine Restriction Affects Acidic Vacuoles 
We next used acridine orange staining to investigate the effect of glutamine limitation on 
acidic organelles.  Sp2/0 cells were cultured for 24h under limiting glutamine conditions, then 
stained with acridine orange (figure 3.24). Glutamine concentrations spanned the range from 
1000 µM (panel A) to 25 µM (panel E). Cells from each sample were then analyzed by 
fluorescence microscopy. In order to assess any change in intensity of staining and be certain to 
capture the 25 µM glutamine cell staining, the exposure time was set on that sample and 
maintained across all samples. In order to compare samples, the intensity of the cells in panel A 
of figure 3.24 and panel A of figure 3.27 were determined to be "bright" and used as a 
comparator.   
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Figure 3.24 - Glutamine Limitation Leads to a Reduction in AO Staining 
Sp2/0 cells were cultured for 24h in the indicated concentration of glutamine, and 
processed for AO staining. An identical exposure time (6 ms) was used for 
samples A-E. A) 1000 µM glutamine B) 250 µM glutamine C) 100 µM glutamine 
D) 50 µM glutamine E) 25 µM glutamine. A shorter exposure time (2 ms) was 
used for panel F (glutamine concentration: 1000 µM). At least 5 fields (totalling 
at least 50 cells) were captured at 400X magnification for each condition of each 
experimental group. Each panel is a representative field of 3 independent 
experiments. 
When observing the staining patterns in panels A-E of figure 3.24, the staining is 
brightest in cells cultured in media supplemented with at least 100 µM of glutamine (panels A-
C). This staining was too intense to identify intracellular structures. A shorter exposure time of 
2ms was used in panel F to show that the intensity of the signal captured is not due to the dye 
having saturated the cell, but rather that the signal in the cytosolic structures was very intense 
The percentage of cells with bright staining was determined and presented in figure 3.25. A 
noticeable drop in the intensity of signal was observed in stained cells that had been cultured in 
medium supplemented with 25 µM and 50 µM glutamine. Interestingly, the latter correspond to 
the glutamine concentrations associated with a decrease in cell viability (figure 3.1).  
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Figure 3.25 - Glutamine Limitation Leads to Reduction of Bright Staining in 
Acidic Compartments  
The Sp2/0 cells presented in figure 3.24 were counted and scored as to intensity 
relative to the 1000 µM glutamine-supplemented group. Data represent the 
average ± SD from 3 independent experiments. The statistical significance was 
assessed by ANOVA + Scheffé's ad hoc test where * is p< 0.05 compared to the 
25 µM glutamine-supplemented group. At least 70 cells were counted for each 
group.  
The results shown in figure 3.25 confirmed that the percentage of cells with bright 
staining was significantly lower when glutamine concentrations in the culture medium were of 
100 µM or less. All together, these data show that the function of acidic cytosolic organelles in 
Sp2/0 cells is affected when glutamine levels in the medium are decreased below a concentration 
threshold. This, in turn, suggests that the autophagic machinery might be compromised when 

































The panels in figure 3.26 are presented to show the presence of cells with an abnormal 
staining pattern in the culture when glutamine was limiting in the medium over a 24h period 
(yellow arrows); these green-stained bodies were not observed in the red filter, nor were they 
observed in the culture conditions containing 100 µM or more of glutamine. In order to have the 
orange staining, cells must be able to maintain an acidic pH; the absence of orange staining while 
the green staining remains indicates that acridine orange is present and bound to DNA but not 
acidified. This indicated that the integrity of the acidic organelle was compromised in these cells. 
Interestingly, the apoptotic body formation, the so-called “popcorn” morphology, was readily 
observed in the 25 µM glutamine condition. 
  
Figure 3.26 - Abnormal Cells in the 25 µM Glutamine Condition  
Panels show the acridine orange staining for the DNA (green in merged 
brightfield on the left panel) and acidic compartment staining (orange in the right 
panel) of cells cultured in 25 µM glutamine as in figure 3.22. The white arrow 
points to a cells stained both green and orange, and the yellow arrows point to 
cells with green staining only. 
The results presented in figure 3.24 and 3.25 illustrated that, when grown under 
glutamine-limiting conditions, Sp2/0 cells had fewer acidic vacuoles that stained intensely with 
acridine orange. The next experiment was aimed at examining the effects of glutamine limitation 
over time on the integrity of acidic vacuoles.  
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Figure 3.27 - Micromolar Levels of Glutamine Affect Cytosolic Acidic 
Organelles Over 24h 
Sp2/0 cells were cultured over a 24h period in medium containing 25 µM 
glutamine. At the indicated time points, the cells were collected and stained with 
AO and the images captured 40X magnification using the same exposure time 
(6ms) for all groups. A) 0h, B) 4h, C) 8h, D) 24h, E) 24h with 4 mM glutamine 
control. At least 5 fields (totalling at least 40 cells) were captured for each 
condition of each experimental group. The panels are representative fields of 3 
independent experiments. 
The results shown in figure 3.27 were as expected. At the start of the experiment (panel 
A), the AO stain was intense and the panel resembles panels A- C of figure 3.24. Likewise, cells 
that were cultured in 1000 µM glutamine (panel E) also had intense AO staining. In panels B and 
C, the AO staining was still intense, though the internal structures of the vacuoles could be 
distinguished and most cells presented with acidic vacuoles found in the centre of the cytoplasm. 
At 24h in culture with 25 µM glutamine (panel D), similarly to panel E of figure 3.23, cells had 
noticeably less intense AO staining, and more of the acidic vacuoles appeared on the periphery 
of the cell, closer to the cell membrane. The effects observed were quantified as in figure 3.25 
and are presented in figure 3.28. 
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Figure 3.28 - Glutamine Limitation Leads to a Time-dependent Reduction in 
Brightly Stained Acidic Organelles  
The Sp2/0 cells presented in figure 3.26 were counted and scored as to intensity 
relative to the 0h group. Data represent the average ± SD from 3 independent 
experiments. Statistical significance was assessed by ANOVA + Scheffé's ad hoc 
test where * is p< 0.05 compared to 0h and ¶ is p< 0.05 compared to 4h. At least 
85 cells were counted for each group.  
At the start of the experiment (0h, baseline), 95% of cells counted had bright staining. 
There was an initial moderate decrease in the percentage of brightly stained cells at the 4h time 
point (74%) which was similar to that seen after 8h in culture (82%). These two conditions were 
not significantly different from each other, but were significantly different from the baseline 
condition. There was a marked decrease at 24h, with only 49% of the cells brightly stained, a 
































cultured in abundant glutamine were not significantly different from baseline, but were 
significantly different from the 4h condition.  
The results presented in figures 3.24, 3.25, 3.27 and 3.28 suggest that glutamine 
limitation can compromise the integrity of the acidic vacuoles in Sp2/0 cells. Interestingly, the 
reduction in AO staining intensity occurred in a time frame which is similar to the pattern of 
caspase-3 activation observed under similar conditions (figure 3.12). This suggests that the loss 
of function of acidic organelles may be an event which contributes to the induction of cell death 
under conditions of glutamine limitation.  
3.2.3 — Constitutive Autophagy Activity is Critical to Sp2/0 Cell Survival 
The presence of acidic vacuoles is a necessary step in the progression of autophagy; the 
contents of autophagosomes must be degraded. Their presence alone is not definitive proof of 
autophagy. In order to verify that autophagosomes were present in Sp2/0 cells, cells cultured 
under varying glutamine conditions were prepared as described and visualized by transmission 
electron microscopy.  
As shown in figure 3.29, Sp2/0 cells cultured in glutamine-rich conditions presented with 
double-membraned vacuoles within the cytoplasm of the cell. In panel A, the vacuole appears to 
contain a mitochondrion. In panel B, the vacuoles are less dense. Panels C and D denote forming 
vesicles (241-243).  
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Figure 3.29 - Vacuoles Are Present in Glutamine-Rich conditions 
Panel shows a cell cultured for 24h in 1000 µM glutamine. After 24h, cells were 
collected and 4 for transmission electron microscopy analysis, as described in the 
Materials and Methods section. Black arrow indicates the presence of vacuoles, 
some containing cellular materials and others in the process of forming. 
When cells were cultured in glutamine limited conditions for 24h (figure 3.30, panels A-
D) the vacuoles were more prominent and more of them contained cellular material. Also, the 
cytoplasm appeared to have more debris accumulated and was not as uniform as the cytoplasm 
of cells cultured in 1 mM glutamine (figure 3.29). This could be attributed to a failure by the cell 
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to successfully complete the autophagic process, where the autophagic vacuoles would have 
encapsulated the cellular materials, but have failed to degrade them.  
 
Figure 3.30 - Vacuoles Are Present in Glutamine-Limited Conditions 
Panel shows cells cultured for 24h in 25 µM glutamine. After 24h, cells were 
collected and processed for transmission electron microscopy analysis, as 
described in the Materials and Methods section. Black arrows indicate the 
presence of vacuoles. 
Our observation of a decrease in the abundance of acidic organelles by acridine orange 
and the prominence of the vacuoles by TEM led us to consider the possibility of an impairment 
of autophagy following glutamine limitation. One protein associated to the autophagic pathway 
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is microtubule-associated light chain 3 (LC3). When the autophagic machinery is not activated, 
the non-lipidated form of LC3, LC3-I, is the predominant form present.  
Upon activation, LC3-I is cleaved to remove a terminal glycine and conjugated to 
phosphatidylethanolamine, becoming LC3-II (244). The addition of the lipid moiety allows for 
the insertion of LC3 into the developing autophagosomal membrane to facilitate membrane 
curvature. The presence of a lipidated form of LC3-II has been reported as being a necessary step 
of autophagy (139).  
Since the results of figures 3.24, 3.25, 3.27 to 3.30 indicated that autophagic vacuoles are 
present in Sp2/0, and that the AO staining was more intense in cells that were cultured in the 
presence of non-limiting amounts of glutamine, we next sought to determine whether LC3 was 
expressed in that cell line, and if so, whether the levels of either LC3 forms would be modulated 
under conditions of glutamine limitation.  
As can be seen from figure 3.31, two forms of LC3 were observed. The LC3-I form was 
most evident in the 1000 µM and 25 µM conditions, and barely detectable in all other conditions. 
The LC3-II form was present in all conditions, with greatest quantity in the 1000 µM and 25 µM 
conditions. To get a better characterization of the increase in expression, the ratio of intensity of 
LC3-II to LC3-I was calculated. In the 1000 µM condition, the LC3-II band was 2.9 fold more 
intense than the LC3-I form, 2.6 fold more intense in the 250 µM condition, 2.8 fold more 
intense in the 100 µM condition, 4.4 fold more intense in 50 µM and 2.8 fold more intense in the 
25 µM condition. This observation was similar across all 3 experiments (see appendix A.3 and 
A.4). The high ratio of LC3-II to LC3-I suggests that autophagy is constitutively activated in 
Sp2/0 cells, irrespective of the glutamine concentration in the medium. 
 97!
 
Figure 3.31 - Glutamine Limitation Modulates LC3-II Expression 
Western blot analysis of protein extracts from cells cultured for 24h in medium 
containing the indicated concentration of glutamine and probed with an anti-LC3 
antibody. An anti-β-actin antibody was used as loading control. Data are 
representative of 3 independent experiments (band densities for all 3 experiments 
are presented in appendix A.3). The density (LC3-II) is the β-actin-normalized 
densitometry reading of the LC3-II band compared to the 1000 µM condition. The 
LC3-II/LC3-I indicates the normalized expression ratio for each condition. 
We next examined the modulation of LC3-I and -II over time in Sp2/0 cells cultured 
under glutamine-limiting conditions (figure 3.32). LC3-II expression, when compared to the 0h 
(baseline) time point, was slightly decreased after 8h of culture in medium containing 25 µM 
glutamine, only to increase for the 24h time point condition. This trend was consistent across the 
experiments (see Appendix A.5) while not being statistically different because of the variations 
in densitometry reading. The LC3-I band was not consistently detectable at the time points 
before the 24h condition. When evaluating the results presented in figures 3.30-3.32, the 
evidence suggests that glutamine limitation causes a decrease in autophagic activity, which is 
proportional to the amount of glutamine in the medium.  
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Figure 3.32 - LC3-II Expression in Glutamine-limited Sp2/0 Cells 
Western blot analysis of protein extracts from Sp2/0 cells cultured over a period 
of 24h in medium containing 25 µM of glutamine. At the indicated time, cells 
were collected and processed for SDS-PAGE electrophoresis and Western 
blotting using an anti-LC3 antibody. An anti-β-actin antibody used to control for 
protein loading. Data are representative of 3 independent experiments. The 
density (LC3II relative to 0h is the β-actin-normalized densitometry reading of the 
LC3-II band compared to the 25 µM condition. 
The presence of acidic vacuoles (figure 3.24) and of the lipidated form of LC3-II when 
cells were not limited by glutamine (figure 3.31) suggested that autophagy may be a constitutive 
process in the Sp2/0 cell line. We attempted to detect the presence of the autophagosome marker 
p62, however this proved to be unsuccessful in the Sp2/0 cell line. This failure could have been 
technical in nature (such as the quality of the antibody) or because p62 was being degraded in the 
autophagosomes. We also attempted to transfect Sp2/0 cells with a GFP-LC3 construct in order 
to use the cleavage of the fusion protein as a reporter for autophagy (245). Unfortunately, while 
Sp2/0 cells could be readily transfected with a plasmid expressing GFP, the expression of the 
GFP-LC3 fusion protein proved to be toxic to the cells. To evaluate the importance of autophagy 
for Sp2/0 cell survival, we tested the effect of chemical inhibitors of autophagy on the behavior 
of Sp2/0 cells cultured under non-limiting glutamine conditions.  
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The autophagy inhibitor 3-methyladenine (3-MA) inhibits class I PI3K, a protein kinase 
that phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-
trisphosphate (PIP3) which leads to AKT activation (246). More importantly, 3-MA also inhibits 
the class III PI3K Vsp34 (247), which produces phosphatidylinositol-3-monophosphate (248) 
and has been implicated in the regulation of autophagy (249). Therefore, we tested the effect of 
3-MA on the behaviour of Sp2/0 cells. 
Sp2/0 cells were cultured for 24h in glutamine-rich (4 mM) medium, with or without 
supplementation with 3-MA. After 24h, the cells were collected and assessed for survival using 
the trypan blue assay (figure 3.33).  
As shown in figure 3.33, the presence of 3-MA in the culture medium resulted in a 
significant loss of viability even at the lowest dose; 23% trypan blue positive cells were present 
in the 1 mM 3-MA condition. When the 5 mM 3-MA supplemented the culture medium, 81% of 
the cell population was trypan blue positive and at the highest concentration (10 mM), 95% of 
the cell population was stained with trypan blue. The concentrations of 3-MA chosen has been 
shown block autophagy in previously published work (249, 250).  
The results presented in figure 3.33 were confirmed by flow cytometry analysis. 7-
aminoactinomycin D (7AAD) is a DNA-binding fluorescent dye that is not membrane 
permeable; as such, only cells having lost their membrane integrity (i.e. late apoptotic or necrotic 
cells) will have a positive 7-AAD signal when assessed by flow cytometry. As seen in figure 
3.34, 3-MA treatment (blue) caused a significant dose-dependent increase in the number of 7-
AAD stained cells when compared to the control (red), confirming that 3-MA treatment triggered 
Sp2/0 cell death.  
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Figure 3.33 - 3-MA Treatment Decreases Cell Viability in Glutamine-Rich 
Conditions 
Sp2/0 cells were cultured in medium containing 4 mM glutamine for a period of 
24h in the presence of the indicated concentration of 3-methyladenine, with 
ddH20 used as the solvent control. Cell viability was then assessed by trypan blue 
exclusion assay. Data represent the average ± SD of 3 independent experiments. 
Statistical significance was assessed by ANOVA + Scheffé's ad hoc test with * 
p<0.05 compared to the 4 mM group. 
While 3-MA is widely used to study autophagy by virtue of inhibiting the activity of 
class III PI3Ks, it is not specific to the autophagic pathway because it can also inhibit class I and 
class III PI3Ks which have been involved in other cellular pathways which include cellular 
trafficking and nutrient signalling (251). In order to confirm the 3-MA data, we used bafilomycin 
A1, another chemical frequently used to inhibit autophagy (241, 252). Bafilomycin A1 acts by 






































pH of the organelle decreases the activity of several of its hydrolytic enzymes, and thus hinders 
the degradation of the contents of the autophagolysosomes.  
 
Figure 3.34 - Sp2/0 Cells Treated With 3MA Lose Membrane Integrity 
Sp2/0 cells were cultured for 24h in medium containing 4 mM glutamine in the 
presence of 3MA treatment (blue) or an equivalent volume of ddH20 (red). The 
cells were then stained with membrane-impermeable 7AAD and analyzed by flow 
cytometry. The concentration of 3MA used in the experiment is indicated in the 
top right corner of each panel. Data are representative of 3 independent 
experiments. MFI: mean fluorescence intensity. 
As shown in figure 3.35, even in glutamine-rich conditions, concentrations of 
bafilomycin A1 as low as 10 nM caused a dramatic increase in the number of dead cells, as 89% 
of cells assessed were trypan blue positive compared to 7% in the solvent control. These data 
were confirmed by the flow cytometry analysis of 7-AAD-stained cells (figure 3.36). The DMSO 
solvent control shows very little 7-AAD staining, whereas all conditions containing bafilomycin 
A1 have a strong 7-AAD signal, indicating loss of membrane integrity.  
 102!
  
Figure 3.35 - Bafilomycin A1 Decreases Cell Viability in Glutamine-Rich 
Conditions 
Sp2/0 cells were cultured in medium containing 4 mM glutamine for a period of 
24h in the presence of the indicated concentrations of bafilomycin A1, with 
DMSO being used as a solvent control. Cell viability was then assessed by the 
trypan blue exclusion assay. The data represents the mean ± SD of 3 independent 
experiments. Statistical significance was assessed by ANOVA + Scheffé's ad hoc 
test with * p<0.05 compared to the 4 mM glutamine control group. 
The induction of cell death by the addition of 3-MA or bafilomycin A1 confirms the 
importance of autophagy for the survival of Sp2/0 cells in typical culture conditions. These 
results also suggest that activation of autophagy may reduce the sensitivity of Sp2/0 cells to 
apoptosis induction when Sp2/0 cells are cultured in glutamine-limited conditions. To test this 
possibility, we evaluated the effects of rapamycin (figure 3.37), a known activator of autophagy 






































Figure 3.36 - Sp2/0 Cells Treated With Bafilomycin A1 Lose Membrane 
Integrity 
Sp2/0 cells were cultured in medium containing 4 mM glutamine for a period of 
24h in the presence of 10 nM bafilomycin A1, with DMSO being used as the 
solvent control. Cells were then processed for 7-AAD staining and flow 
cytometry analysis. Data presented is representative of 3 independent 
experiments. MFI: mean fluorescence intensity.  
First, Sp2/0 cells were cultured for 24h in culture medium containing 4 mM glutamine 
and a range of rapamycin concentrations. DMSO was included as a negative control. As shown 
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in figure 3.37, rapamycin alone did not reduce cell viability when compared to the 4 mM 
glutamine control. However, cells cultured in rapamycin did have a statistically significant dose-
dependent reduction in cell density. They showed reduced capacity to proliferate when compared 
to the 4 mM glutamine condition. This was not unexpected considering that mTOR is known to 
positively regulate proliferation.  
 
Figure 3.37 - Rapamycin Prevents Increase in Cell Density in Glutamine-
Rich Conditions  
Sp2/0 cells were cultured in medium supplemented with 4 mM glutamine for a 
period of 24h in the presence of the indicated concentration of rapamycin, with 
DMSO as the solvent control. Cell viability and density were then assessed by the 
trypan blue exclusion assay. Data represent the mean ± SD of 3 independent 
experiments. Statistical significance for cell density was determined assessed by 
two tailed paired t-test with * p<0.05 compared to 4 mM. 
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Since rapamycin treatment did not have any toxic effect on Sp2/0 cell cultured in 
glutamine-rich conditions, we next tested the effects of this autophagy inducer on Sp2/0 cells 
cultured for 24h under glutamine-limiting conditions. Remarkably, our results showed that, at 
concentrations of 50 nM and 100 nM, rapamycin treatment markedly improved the viability of 
Sp2/0 cells cultured in medium supplemented with 25 µM glutamine, with no discernible effect 
on cell density (figure 3.38).  
  
Figure 3.38 - Rapamycin Rescues Cell Viability in Glutamine-Limited 
Conditions  
Sp2/0 cells were cultured in medium containing 25 µM glutamine for a period of 
24h in the presence of the indicated concentrations of rapamycin, with DMSO 
included as the solvent control. Cell viability was then assessed by the trypan blue 
exclusion assay. Data represent the mean ± SD of 3 independent experiments. 
Statistical significance was determined by paired two-tailed t-test with * p<0.05 
compared to the 25 µM glutamine control 25 µM. 
 106!
3.2.4 — Chapter Summary 
Overall, the results presented in Chapter 3.2 show that autophagy is not only present in 
Sp2/0 cells, but that it is an important mechanism for cellular survival. Autophagy markers were 
more evident in glutamine-rich conditions than in glutamine-limited conditions. The results 
presented show that autophagy inhibition either early (with 3-MA) or late in the signalling 
cascades (with bafilomycin A1) leads to a high proportion of Sp2/0 cell death. In contrast, in 
glutamine-limited conditions, autophagy activation by the mTOR inhibitor rapamycin increased 
cell survival but not the capacity to proliferate.  
The results suggest a link between glutamine, autophagic activity and cell survival: in 
glutamine-rich conditions, autophagy is active and cells survive and proliferate while in 
glutamine-limited conditions, cells do not proliferate, autophagy markers are decreased and cells 
are apoptotic. If autophagy is stimulated by rapamycin in glutamine-limited conditions, cell 
viability is rescued though there is no concomitant increase in cell density. If autophagy is 
inhibited in glutamine-rich conditions, cells are not viable. The next section aims to explore in 
greater detail the potential relationship between Sp2/0 cell viability, glutamine and autophagy. 
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CHAPTER 3.3 — GLUTAMINE LINK TO AUTOPHAGY 
The Sp2/0 cell line is addicted to glutamine and cannot survive in its absence. The 
previous sections (3.1 and 3.2) have characterized the response in this cell model to limiting 
concentration of glutamine and showed the importance of autophagy for Sp2/0 cell survival. The 
link between glutamine, autophagy and cell survival may reside in the metabolism of glutamine 
within the cell. When glutamine is metabolized to enter the TCA cycle, it releases an ammonium 
ion (NH4+) via the action of glutaminase (6, 169).  
 
A recent study showed that ammonium ions derived from glutamine metabolism 
stimulate autophagy. Moreover, this stimulatory effect was correlated to an increase in cell 
survival in an osteosarcoma cell line (U2OS) and in kidney epithelial cells (iBMK) (169, 231).  
The results obtained thus far, and described in sections 3.1 and 3.2 of this thesis, have 
demonstrated that glutamine is critical to Sp2/0 cell survival and proliferation. Sp2/0 cells grown 
in medium containing less than 100 µM of glutamine do not proliferate, die by apoptosis, have 
prominent cytoplasmic vacuoles containing cellular materials, less intense acridine orange 
staining, and show lower LC3-II expression. Furthermore, when Sp2/0 cells were cultured in 
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medium containing limiting amounts of glutamine, the inclusion of the mTOR inhibitor 
rapamycin led to a significant decrease in cell viability.  
Considering the information reported by Eng et al. (169) in the context of the Sp2/0 cell 
line, we next assessed whether ammonium ions could be a mechanism by which glutamine 
promotes Sp2/0 cell survival. 
3.3.1 — Ammonium Ions Affect Cell Viability and Proliferation 
We first examined whether ammonium ions could modulate the viability of Sp2/0 cells 
grown under conditions of glutamine limitation. Two different sources of ammonium ions were 
used: an organic source, ammonium acetate (AA) and an inorganic source, ammonium chloride 
(ACl). Sodium acetate (NaA) and sodium chloride (NaCl) were used to assess whether the effect 
observed was due to the ammonium ion or the anion. Sp2/0 cells were cultured for 24h in 
medium containing 25 µM glutamine and supplemented with either AA, NaA, ACl or NaCl.  
The effects of the ammonium salts on Sp2/0 cells were quite striking and could be 
qualitatively assessed by microscopy (figure 3.39 A-H). While Sp2/0 cells grown for 24h in the 
presence of 25 µM glutamine were clearly apoptotic (B), the addition of either ammonium salt 
increased cell density and seemed to increase the number of viable cells (C-D, F-G) to resemble 
the 4 mM glutamine control, while sodium salts had no such rescue effect (E, H). 
The effect of ammonium ions on Sp2/0 cell viability and proliferation was confirmed 
using the trypan blue exclusion assay. When cells were cultured under limiting glutamine 
conditions (25 µM), the average percentage of dead cells was 57.39% (figure 3.40). Treatment of 
cells cultured under glutamine-limited conditions with either ammonium salt significantly 
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decreased the number of dead cells, with 17.98% when treated with AA and 28.97% when 
treated with ACl. This effect was specific to ammonium salt treatment as sodium salt treatments 
had no significant effect on cell viability.  
 
Figure 3.39 - Effect of Ammonium Ions on the Morphology of Sp2/0 Cells 
Grown Under Conditions of Glutamine Limitation  
Pictures taken at 100X magnification in brightfield by light microscopy of Sp2/0 
cells cultured in medium containing 25 µM glutamine for a period of 24h. The 
cultures also included a source of ammonium ions or the corresponding sodium 
counter-ion control. A) 4 mM glutamine, B) 25 µM glutamine, C) 5 mM 
ammonium acetate, D) 10 mM ammonium acetate, E) 10 mM sodium acetate, F) 
5 mM ammonium chloride, G) 10 mM ammonium chloride, H) 10 mM sodium 
chloride.  
We next assessed the effect of ammonium ions on cell proliferation. AA and ACl both 
caused a significant increase in cell density compared to the control sample (figure 3.40): while 
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the 25 µM glutamine control had a cell density of 3.12x105 cells/mL, the cultures treated with 
AA and ACl reached 1.13x106 and 8.80x105 cells/mL, respectively. The cultures treated with 
sodium salts showed no significant change in cell density compared to the control. These results 
suggest that ammonium ions have a protective effect on viability and a potentiating effect on cell 
proliferation when Sp2/0 cells were cultured in glutamine-limited conditions.  
 
Figure 3.40 - Ammonium Ion Treatment Increases Cell Density and Viability 
in Glutamine-Limited Conditions 
Sp2/0 cells were cultured for a period of 24h in medium containing 25 µM 
glutamine and supplemented with 5 mM of the indicated salt. Cell density and 
viability were then determined by the trypan blue staining assay. Data are the 
average ± SD of 3 independent experiments. * represent p<0.05 by ANOVA with 
Scheffé's post-hoc test when compared to the 25 µM glutamine control condition. 














































We next sought to confirm these data using a clonogenic assay, which is a more stringent 
test for measuring cell survival (254). When Sp2/0 cells cultured under glutamine limitation 
conditions were tested in a clonogenic assay, supplementation with either ammonium salts led to 
a significant increase in the number of colonies over the untreated control (figure 3.41).  
 
Figure 3.41 - Treatment With Ammonium Ions Increase Sp2/0 Cell Survival 
in Glutamine-limited Conditions 
Sp2/0 cells were cultured for a period of 24h in medium containing 25 µM 
glutamine in the presence of 5 mM of the indicated ammonium or sodium salts. 
The cells were then processed for the clonogenic assay, as described in the 
Material and Methods section. The data presented are the average ± SD of the 
fold change in the number of colonies compared to the 25 µM glutamine control 
group (from 3 independent experiments). The star (*) represents p<0.05 in a 
paired two-tailed t-test when compared to the control group. AA: ammonium 


























Neither sodium salt controls provided a beneficial effect on viability. These results 
therefore confirm that that ammonium ions can stimulate cell survival of Sp2/0 grown under 
glutamine-limiting conditions. They also raise the possibility that part of the effect of glutamine 
on cell viability can be effected by the ammonium ions released following the catabolism of the 
amino acid.  
3.3.2 — Ammonium Salt Treatment Decreases Cell Death 
The results shown in figures 3.39-3.41 indicate that Sp2/0 cells are more viable and able 
to sustain proliferation in glutamine restricted conditions when ammonium salts are supplied in 
the medium. We next addressed the question of whether ammonium ions acted by interfering 
with apoptosis. To this aim, we first used the Annexin V/propidium iodide (PI) staining assay. 
Annexin V is a protein which binds phosphatidylserine (PS), a major phospholipid component of 
the inner leaflet of the plasma membrane. Propidium iodide is a non cell-permeable, DNA 
intercalating agent. In apoptotic cells, PS is exposed on the outer leaflet of the plasma membrane, 
and will be accessible to Annexin V. However, early apoptotic cells still have an intact plasma 
membrane and will not stain with PI. On the other hand, late apoptotic and necrotic cells have 
lost membrane integrity, allowing Annexin V to bind PS on the inner leaflet of the plasma 
membrane, and PI to bind DNA. Thus, this assay can be used to discriminate between viable 
(Annexin V negative/PI negative), early apoptotic (Annexin V positive/PI negative) and late 
apoptotic/necrotic cells (Annexin V positive/PI positive). 
Figure 3.42 shows the results of an Annexin V/PI staining experiments when Sp2/0 cells 
were cultured for 24h under glutamine limitation conditions, in the presence of increasing 
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amounts of ammonium acetate. Cells cultured in medium containing 4 mM glutamine or under 
glutamine deprivation conditions were used as controls.  
 
Figure 3.42 - Ammonium Acetate Treatment Protects Against Cell Death in 
Glutamine-limited Conditions 
Sp2/0 cells were cultured for 24h under the indicated conditions before being 
processed for Annexin V and PI staining and subjected to flow cytometry 
analysis. Cells cultured in medium containing 4 mM glutamine (4 mM Q), under 
glutamine deprivation conditions (0 Q), or subjected to glutamine limitation (25 
µM Q) were used as controls. Data are the mean ± SD of three independent 
experiments.* indicates p<0.05 in a paired t-test when compared to the 25 µM Q 
condition. AA: ammonium acetate. 
For the control condition, the cells cultured in medium containing 4 mM glutamine had 
8.10% of cells that were Annexin V positive, 96.83% of the cells were Annexin V positive when 







































staining when cultured under glutamine-limiting conditions. When glutamine-limited Sp2/0 cells 
were treated with AA, 30.27% of cells were Annexin V positive in the 1000 µM AA condition, 
24.33% in the 2.5 mM AA condition, 19.47% in the 5 mM AA condition and 17.90% in the 10 
mM AA condition.  
For PI staining, the culture control conditions had 5.93% (4 mM glutamine), 95.93% 
(glutamine-deprived) and 37.30% (glutamine-limited) PI-positive cells respectively. 
Supplementing the culture medium with AA led to a significant decrease in PI staining, with 
19.70% PI-positive cells in the 1000 µM AA condition, 14.87% in the 2.5 mM AA condition, 
11.83% in the 5 mM AA condition and 10.77% in the 10 mM AA condition. 
The percentage of Annexin V positive or PI positive cells decreased when cells cultured 
in 25 µM glutamine were treated with AA, and the decrease was more important as the 
concentration of AA increased, and when compared to the 25 µM glutamine condition. The 
percentage of cells positive for Annexin V indicate that cells are either apoptotic or necrotic, but 
does not discriminate between the two. However, cells that are positive of Annexin V staining 
but negative for PI are apoptotic because they have exposed PS on the outer leaflet of the plasma 
membrane but have not lost membrane integrity. The percentage of cells that are Annexin V+/PI- 
is shown in figure 3.43. For the culture control conditions 3.54% of the cells were Annexin 
V+/PI- in the 4 mM glutamine group, 2.33% were Annexin V+/PI- in the glutamine-deprived 
group (0Q) and 16.70% were Annexin V+/PI- in the glutamine-limited culture. When the 
glutamine-limited cultures were supplemented with AA, 11.40% of cells were Annexin V+/PI- in 
the 1000 µM AA group, 9.73% in the 2.5 mM AA sample, 8.07% in the 5 mM AA condition and 
7.43% in the 10 mM AA group. Therefore, these data show that AA treatment decreases the 
percentage of cells that are apoptotic when subjected to glutamine-limiting condition. 
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Figure 3.43 - Ammonium Acetate Treatment Prevents Apoptosis 
Cells were cultured for 24h in the indicated conditions before being stained and 
subjected to analysis by flow cytometry with Annexin V and PI. 4 mM glutamine 
is the culture control condition, and 0 glutamine controls for glutamine-
deprivation. Data are the mean of three independent experiments ± standard 
deviations. * indicates p<0.05 in a paired t-test when compared to the 25 µM 
glutamine condition. Q: glutamine, AA: ammonium acetate. 
Unexpectedly, somewhat different results were obtained when the effect of ACl was 
studied. As shown in Figure 3.44, Sp2/0 cells cultured for 24h under glutamine limitation 
conditions had 34.73% of cells positive for Annexin V in the 1000 µM ACl group, 31.20% in the 
2.5 mM ACl sample, 29.27% in the 5 mM AA condition and 32.52% in the 10 mM AA group 
(since this experiment was performed at the same time as Figure 3.42, the 3 controls were the 































1000 µM AA condition, 16.87% in the 2.5 mM AA condition, 14.40% in the 5 mM AA 
condition and 17.40% in the 10 mM AA condition.  
 
Figure 3.44 - Annexin V and PI Staining With Ammonium Chloride 
Treatment 
Sp2/0 cells were cultured for a period of 24h under the indicated conditions 
before being processed for Annexin V / PI staining and analysed by flow 
cytometry. Cells cultured in medium containing 4 mM glutamine (4 mM Q), 
under glutamine deprivation conditions (0 Q), or subjected to glutamine limitation 
(25 µM Q) were used as controls. Data are the mean ± SD of three independent 
experiments. The star (*) denotes p<0.05 in a paired t-test when compared to the 
glutamine-limited (25 µM) for Annexin V staining, ¶ denotes p<0.05 in a paired t-
test when compared to the glutamine-limited (25 µM) group for PI staining. Q: 
glutamine, ACl: ammonium chloride. 
Therefore, ammonium chloride is not as effective as ammonium acetate in preventing cell 

















































treatment groups. The degree of protection from cell death afforded Sp2/0 cells was optimal at 5 
mM ACl; there was no statistically significant difference between the results obtained for 5 mM 
and 10 mM ACl treatments. Figure 3.45 presents the percentage of early apoptotic cells (i.e. 
Annexin V+ / PI-) in the ACl treatment group.  
 
Figure 3.45 - Annexin V+/PI- Staining with Ammonium Chloride Treatment 
Cells were cultured for 24h in the indicated conditions before being stained and 
subjected to analysis by flow cytometry with Annexin V and PI. 4 mM glutamine 
is the culture control condition, and 0 glutamine controls for glutamine-
deprivation. Data are the mean of three independent experiments ± standard 
deviations.* Denotes p<0.05 in a paired t-test when compared to the 25 µM 
glutamine condition. Q: glutamine, ACl: ammonium chloride. 
The control conditions were the same as those shown in the figure 3.43, since these 



























14.33% of cells were Annexin V+/PI- when exposed to 1000 µM ACl, 14.27% in the 2.5 mM 
ACl condition, 15.20% in the 5 mM ACl group and 15.73% in the 10 mM ACl sample. These 
data show that ACl treatment does not affect the percentage of early apoptotic cells under 
glutamine-limiting conditions. 
These data thus far (figures 3.39 to 3.45) indicate that cells are protected from death 
when treated with either ammonium salt in restricted glutamine conditions, but that only 
ammonium acetate treatment decreases the percentage of early apoptotic cells.  
3.3.3 — Caspase-3 Activity 
The presence of ammonium salts in the culture medium protected Sp2/0 cells from cell 
death under glutamine-restricted conditions, but differed in the way they affected apoptosis. In 
order to better tease out the effects of ammonium salts on apoptosis, the activation state of 
caspase-3 was assessed in Sp2/0 cell cultured under conditions of glutamine limitation, in the 
presence of either ammonium acetate, ammonium chloride, or the corresponding sodium salt 
controls. 
The caspase-3 in vitro peptide cleavage assay results presented in figure 3.46 confirmed 
the Annexin V staining observations. The ammonium acetate treatment decreased the caspase-3 
activity to 0.46 of the control condition while ammonium chloride treatment increased the 
activity to 1.51 fold, a statistically significant difference. Caspase-3 activity in cells cultured in 
the presence of sodium acetate or sodium chloride was was 1.27 and 1.38 fold higher than the 
control, respectively. Neither of these two treatments was statistically different from either the 25 
µM glutamine or the ammonium chloride conditions. The conclusion to be drawn is that sodium 
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salts did not have an effect on caspase activity, but that both ammonium molecules did have 
modulatory effect, but the effects observed were opposite. The difference between the molecules 
rests with the nature of the anion, whether it be organic or inorganic in nature. It is possible that 
the organic nature of acetate would be more easily absorbable, or that it would provide additional 
carbons that could be metabolized within the cell.  
 
Figure 3.46 - Ammonium Salt Treatment Modulates Caspase-3 Activity 
Sp2/0 cells were cultured for 24h in medium containing 25 µM glutamine and the 
indicated ammonium or sodium salts. The cells were then collected and processed 
for the caspase-3 activity assay, as described in the Materials and Methods 
section. Data are the mean fold change of three independent experiments ± 
standard deviations. The star (*) denotes p<0.05 in a paired t-test when compared 
to the control group. AA: ammonium acetate, NaA: sodium acetate, ACl: 

































3.3.4 — Ammonium Salts Preserve Acidic Vesicles 
Ammonium salt treatment has been reported to protect cells from apoptotic death by 
activating the autophagy pathway (169, 231). In order to assess the effect of ammonium salts on 
the autophagy pathway, the presence of acidic vesicles was assessed using acridine orange 
staining.  The panel shown in figure 3.47 presents pictures of cells cultured for 24h in medium 
containing 25 µM glutamine and supplemented with ammonium or sodium salts.  
Cells cultured under conditions of glutamine deprivation (0 mM, panel A) or glutamine 
sufficiency (4 mM, panel B) were used as controls. The cells were then processed for AO 
staining and observed by fluorescence microscopy. Under conditions of glutamine deprivation, 
few cells could be observed and they had very diffuse staining. When the cells were cultured in 
medium containing 4 mM glutamine, the cell density was much greater and the AO staining 
brighter. Under conditions of glutamine limitation (25 µM, panel C), some of the cells had a 
uniform shape and were brightly stained, while others have diffuse staining and the presence of 
apoptotic bodies can be observed (white arrows).  
When cells cultured under glutamine-limiting cells were treated with 5 mM AA, they 
more closely resembled the 4 mM glutamine condition: there were few apoptotic bodies visible, 
a greater number of cells were present in each field, and the acridine orange staining was of a 
similar intensity (panels B and D). When Sp2/0 cells cultured in 25 µM Q were treated with 5 
mM NaA, the rescue phenomenon disappeared: cells were few, the presence of apoptotic bodies 
was readily observed and the intensity of the staining was decreased, much like the 25 µM Q 
condition (panels C and E). Treatment with ammonium chloride had an effect similar to that seen 
with ammonium acetate, with more cells in each field than the 25 µM Q condition, but not as 
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Figure 3.47 - Ammonium Salts Preserve Acidic Vesicles in Glutamine 
Restriction 
Sp2/0 cells were cultured over a 24h period in medium containing 25 µM 
glutamine, with or without supplementation with ammonium salts or the 
corresponding sodium salt. After 24h, the cells were collected and stained with 
AO and the images captured using the same exposure time (6ms) for all groups. 
A) 0 Q, B) 4 mM Q, C) 25 µM Q, D) 25 µM + 5 mM AA, E) 25 µM Q + 5 mM 
NaA, F) 25 µM Q + 5 mM ACl, G) 25 µM Q + 5 mM NaCl. At least 5 fields 
(totalling at least 40 cells) were captured at 40X magnification for each condition 
of each experimental group. The panels are representative fields of 3 independent 
experiments. AA: ammonium acetate, NaA: sodium acetate, ACl: ammonium 
chloride, NaCl: sodium chloride. White arrows indicate the presence of apoptotic 
bodies. 
many as the ammonium acetate condition, intense acridine orange staining and few apoptotic 
vesicles present in the fields (panel F) and sodium chloride, like sodium acetate, had no 
protective effect (panel G).  
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The staining of acidic vesicles with acridine orange presented in figure 3.48 was 
quantified and is presented in figure 3.49. The intensity of the Sp2/0 cell staining was scored 
compared to the staining of cells cultured for 24h in medium supplemented 4 mM glutamine 
condition.  
  
Figure 3.48 - Quantitation of the Rescue Effect of Ammonium Salts  
The Sp2/0 cells presented in figure 3.47 were counted and scored as to intensity 
relative to the 4 mM glutamine group. Data represent the average ± SD from 3 
independent experiments. Statistical significance assessed by paired t-test with * 
p<0.05 in a paired t-test when compared to the 25 µM Q condition. ¶ p<0.05 in a 
paired t-test when the AA condition was compared to ACl condition. AA: 



































In Sp2/0 cells cultured for 24h in medium supplemented with 4 mM Q, 89.73% of cells 
had bright AO staining. In the medium not supplemented with glutamine, 3.21% of cells had 
bright AO staining. In the cells cultured in medium supplemented with 25 µM glutamine, 
32.52% of cells had bright AO staining, with 70.40% with AA treatment, 59.54% with ACl 
treatment, 40.37% with NaA treatment and 30.73% with NaCl. The difference between the 25 
µM glutamine control group and those treated with either ammonium salt was statistically 
significant. It should be noted that the difference between the two ammonium salt treatments was 
also significant. It should be cautioned that these were not blinded experiments. However, the 
flow cytometry experiments with Annexin V and PI staining and the Western blot experiments 
also indicate that there is a differential effect between the ammonium samples and the sodium 
samples. New techniques would allow for the unbiased quantitation of acidic vesicles by flow 
cytometry to confirm this observation, and are described in section 4.1 (255).  
The acridine orange staining indicated that ammonium salt treatment modulated the 
ability and number of acidic vacuoles with a rescue effect that resembled that conferred by a 
culture medium containing a sufficient amount of glutamine. The presence of acidic vacuoles is 
crucial to the proper degradation of cellular materials during autophagy (133, 210) and so the 
next experiment was designed to determine the expression of LC3 in Sp2/0 cells treated with 
glutamine. Cells were cultured for 24h in 25 µM glutamine with or without ammonium salt 
treatment or the corresponding sodium salt control. A representative image is presented in figure 
3.49.  
When comparing to the 25 M glutamine, the LC3-II band in the AA condition was 2.04 
fold more intense, 1.51 fold more intense in the ACl condition, was less intense (0.6 fold 
intensity) in the NaA, and relatively similar (1.07 intensity) in the NaCl condition. In all 
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experiments, the intensity of the LC3-II band was more intense with AA and ACl treatments and 
either a decrease or similar intensity with NaCl and NaA (see appendix A.6). The presence of the 
LC3-I form was also more evident in the sodium salt-supplemented cultures and the 25 µM 
glutamine conditions, but was not consistently present across all experiments. Thus, ammonium 
salt treatment was associated with increased presence of autophagosome-associated LC3-II, 
which would suggest a higher rate of autophagy. In the conditions where ammonium ions were 
not supplied, less autophagosome-associated LC3-II was present and the more evident presence 
of LC3-I band indicates that autophagy may be present but at a lower rate.  
 
Figure 3.49 - Ammonium Salts Increase LC3-II Expression in Glutamine 
Limitation 
Western blot analysis of protein extracts from Sp2/0 cells cultured over a period 
of 24h in medium containing 25 µM of glutamine cells. At 24h cells were 
collected and processed for Western blot analysis with an anti-LC3 antibody. An 
anti-β-actin antibody used to control for protein loading. Data are representative 
of 3 independent experiments (see appendix A.5). Density of LC3II relative to the 
25 µM Q condition is the β-actin-normalized densitometry reading ratio of the 
LC3-II band compared to the 25 µM condition. AA: ammonium acetate, NaA: 
sodium acetate, ACl: ammonium chloride, NaCl: sodium chloride. 
In order to confirm the presence of autophagic vacuoles, transmission electron 
microscopy was also performed (see figure 3.50).  When comparing the ammonium salt
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Figure 3.50 - Ammonium and Sodium Salt Treatments 
Panel shows cells cultured for 24h in 25 µM glutamine with the following salt 
treatments: A) ammonium acetate, B) ammonium chloride, C) sodium acetate, D) 
sodium chloride. After 24h, cells were collected and processed for transmission 
electron microscopy analysis, as described in the Materials and Methods section. 
Black arrows indicate the presence of vacuoles. 
 treatments (panels A and B) to the sodium salt treatments (panels C and D), vacuoles can be 
observed in all treatments (black arrows). What is striking is the quality of the cytoplasm. The 
sodium treatments appear to have more vacuoles with less electron density than the ammonium 
treatments. In fact, the cytoplasm from Sp2/0 cells cultured in 25 µM glutamine and treated with 
ammonium salt (panels A and B) resemble those observed in the cells culture in glutamine-rich 
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conditions (see figure 3.29), while those treated with sodium salts resemble cells cultured in 25 
µM glutamine (see figure 3.30).  
It is noteworthy that more vacuoles containing materials can be observed in panels A and 
B than can be observed in the panels from Sp2/0 cells cultured in glutamine-rich conditions 
(figure 3.29). The structures resemble whorl-like autophagosomes reported to contain ribosomes. 
It was hypothesized that the whorl-like appearance of the autophagosome arose because the 
membranes originated from the Golgi apparatus, a hypothesis supported by the close association 
of ribosomes with the Golgi apparatus (256). It is possible that this difference is due to the 
availability of glutamine in culture media. While ammonium salt treatments did increase cell 
viability and cell density, cells did not survive to the same extent as those cultured in glutamine-
rich medium (see figures 3.30, 3.42 and 3.44). The accumulation of empty cytoplasmic vacuoles, 
as observed in panels C-D, have been reported in nutrient depletion (257).    
3.3.5 — Chapter Summary 
The results presented in this section of my thesis allow for the conclusion that 
supplementation with ammonium ions rescues not only cell viability but proliferation in Sp2/0 
cells cultured under glutamine-limiting conditions. Glutamine-restricted culture conditions do 
not allow for cellular proliferation in Sp2/0 cells; yet Sp2/0 cells cultured in glutamine-restricted 
medium supplemented with ammonium salts proliferated (figure 3.40). Caspase-3 is activated 
and cells stain with Annexin V when glutamine availability is limited yet ammonium acetate 
decreased caspase-3 activity, demonstrating a decrease in apoptotic death (figure 3.46). Acridine 
orange staining and LC3-II expression where increased in cells treated with ammonium salts, 
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suggesting that the degree of autophagy was increased in these treated cells when compared to 
untreated cells (figures 3.48 3.49).  
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4.0 — DISCUSSION 
4.1 — Glutamine Limitation, Ammonium and Autophagy 
Our research group has previously shown that Sp2/0 cells are "addicted" to glutamine 
(53), and the results of figure 3.2 and 3.3 show that there exists a critical threshold concentration 
of glutamine (100 µM) that affects cellular fate. At this critical threshold, cells are viable, but 
don't proliferate. Above this threshold concentration of glutamine, cells proliferate, and below it, 
they undergo apoptosis (see figure 3.4). The results of the AO staining shown in Fig, 3.24 
confirmed that the percentage of cells with bright staining was significantly lower when 
glutamine concentrations in the culture medium were of 100 µM or less. At 25 µM, TEM panels 
show an accumulation of vacuoles containing undegraded structures within the cytoplasm (figure 
3.30), and an accumulation of unlipidated LC3-I (figure 3.31). All together, these data show that 
the function of acidic cytosolic organelles in Sp2/0 cells is affected when glutamine levels in the 
medium are decreased below the critical threshold. This, in turn, suggests that the autophagic 
machinery might be compromised when cell culture levels drop below this threshold.  
Interestingly, when Sp2/0 cells were cultured in medium containing 25 µM glutamine, 
we observed the transient activation of caspase 3. While caspase-3 was clearly activated after 4h 
of culture in medium containing 25 µM glutamine, the activity of this protease was significantly 
diminished at 8h, and resumed after 12h. That this was accompanied by a transient cytoplasmic 
release of cytochrome c suggests that the biphasic activation of caspase-3 could originate from 
the presence of two populations of Sp2/0 cells which differ in their sensitivity to undergo 
apoptosis. It is interesting to note that a ubiquitin ligase (PARC/CUL9) promoting cell survival 
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and targeting cytochrome c for degradation has been recently identified (258). Whether or not 
the expression or activity of PARC/CUL9 is altered in Sp2/0 exposed to limited concentrations 
of glutamine remains to be determined.  It is possible that a subset of the cell population is 
undergoing apoptosis. The resulting apoptotic bodies could be phagocytosed by adjacent cells to 
provide them with nutrients, glutamine and ammonia to stimulate autophagy (259). It is also 
possible that the cell cycle phase in which cells experience nutrient deprivation would render 
them more susceptible to enter the apoptotic cascade (figure 3.19). Whether this hypothesis is 
correct could be assessed by investigating the effect of glutamine limitation over time in the 
presence or absence of autophagy inhibitors 3-MA and bafilomycin A1 or autophagy stimulators 
rapamycin and ammonium. These experiments would help elucidate whether the stimulation of 
autophagy is indeed the reason why apoptosis occurs as biphasic process, and whether mTOR is 
involved in this response.  
In addition to ULK-independent autophagy, other pathways for the non-canonical 
formation of autophagosomes have been described which bypass the canonical nucleation and 
elongation phases and would therefore not be responsive to 3-MA inhibition (260, 261). 
However, as these pathways were described in ATG5 null constructs, in infection models or in 
epithelial cells, it is unlikely to be the major contributing factor in Sp2/0 cells under glutamine-
limiting conditions. It should be noted as a comparison that autophagy inhibitors 3-MA and 
bafilomycin A1have been used in similar concentrations in other bodies of work. In one study 
using both 3-MA and bafilomycin A1 in HeLa cells, the authors inhibited autophagy with 10 
mM 3-MA and 100 nM bafilomycin (262). Another work reports a concentration of 1nM 
bafilomycin A1 in several human colon cell lines (252). In HeLa cells, when inhibition of PI3K 
was employed including 3-MA at 5 mM, mitotic cell death was triggered (263, 264).  
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The results further indicate that in the Sp2/0 cell line, the autophagic machinery is 
constitutively activated (figures 3.23, 3.30) and that it is required for survival. There is 
supporting evidence in the literature for these observations both in vivo and in vitro. In the 
experiments where autophagy was inhibited by 3-MA (figure 3.32) or bafilomycin A1 (figure 
3.34), cell survival was lost even in glutamine-rich conditions. This could be confirmed by 
ATG5 knockdown experiments. It is expected that successful knockdown of ATG5 would result 
in a loss of Sp2/0 cell survival as ATG5 is required for the elongation of the autophagosomal 
membrane (265).  Conversely, when autophagy was stimulated, Sp2/0 cells grown in glutamine-
limiting conditions could survive (figure 3.36). Alternatively, ROS have been shown to stimulate 
autophagy, and thus ROS-generating treatments could be used to confirm this phenomenon in the 
absence of mTOR inhibition (266). Cannabinoid receptor 1 (CB1) inhibitors have also been 
reported to increase autophagic flux independent of mTOR inhibition and Beclin-1. As 
lymphomas have been reported to express different levels of CB1, this could also be another 
potential way of stimulating autophagy in Sp2 cells (267, 268).   
The presence of autophagy in tumour cells is not a new discovery. In fact, LC3B has been 
identified a marker of solid tumour progression, proliferation and metastasis, and the pro-
survival or pro-apoptotic role of autophagy in cancer is largely dependent on the tumour type and 
context (238, 269, 270). In a recent report in kidney cells, a high basal level of autophagy was 
required for normal kidney function both in vivo and in vitro (250). Inhibition of autophagy with 
3-MA was shown to induce ER stress, as indicated by an elevation of GRP78 and GADD-153 
expression, and subsequently induce apoptosis. The authors further demonstrated that the 
apoptosis induced by autophagy inhibition was mediated by GADD-153, as knock-down of 
GADD-153 decreased the autophagy inhibition-induced apoptosis (250). In contrast, our studies 
 131!
show that glutamine limitation did not induce ER stress, as GRP78 expression was unchanged 
while GADD-153 expression was increased (figure 3.5), indicating that GADD-153 expression 
in glutamine limitation may have a different function than that seen in ER stress. GADD-153 
knock-down experiments in Sp2/0 cells subjected to glutamine-limiting conditions may shed 
some light on the role of GADD-153 in autophagy, if any. To assess whether GADD-153 
contributes to apoptosis or to survival by adaption in this cellular model, the expression of 
GADD-153 could be assessed in ammonium-supplemented medium and 25 µM glutamine, 
conditions under which this work has shown Sp2/0 cells survive and proliferate. The expression 
of GADD-153 is not likely to trigger apoptosis through mitochondrial dysfunction, as its 
expression was not modulated by caspase inhibition and was not present in the absence of 
glutamine unless Bcl-XL was expressed by transfection (see figures 3.7 and 3.9). Since Bcl-XL 
afforded a measure of protection against cell death that was similar to that observed by the 
addition of micromolar amounts of glutamine (see figure 3.8) or caspase-inhibition (see figure 
3.6), it is possible that the up-regulation of GADD-153 may require intact mitochondria, which 
Bcl-xL would provide, and it may then influence downstream events of the stress 
response/apoptotic processes. The role of Bcl-XL or caspase inhibition in autophagy would also 
need to be elucidated. It would be interesting to investigate whether bafilomycin A1, 3-MA and 
rapamycin can modulate the expression of GADD-153 in glutamine-limiting conditions, and 
conversely, whether GADD-153 knockdown experiments would have any effect of autophagy.  
Lung adenocarcinoma cells that were epidermal growth-factor independent displayed 
higher levels of basal autophagy than their growth-factor dependent counterparts (271). The 
constant activation of autophagy allowed the cells to thrive in vitro in hypoxic, reduced-serum 
conditions, mimicking the tumour microenvironment. Autophagy inhibition by either 
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chloroquine or ATG5 depletion led to a decrease in cell viability. The authors of this report also 
report the presence of autophagosomes in lung cancer patient samples with epidermal growth 
factor receptor mutations (271). In myc-transformed tamoxifen-inducible p53 murine model, 
lymphoma tumour cells were resistant to apoptosis due to a lack of nuclear p53 (272).  The 
systemic administration of tamoxifen induced the expression of p53, which led to the induction 
of apoptosis and tumour regression. But while apoptosis was induced in some cells, autophagy 
was triggered in others which led to tumour recurrence. When apoptosis was induced and 
autophagy inhibited concurrently, cells then became susceptible to apoptosis (272). In Ras-
transformed mouse embryonic fibroblasts and in human transformed cell lines from colon (HCT-
116 and DLD-1) and cervical epithelium (HeLa), treatment with Ras inhibitor 
farnesylthiosalicylic acid induced autophagy and enhanced cell survival. However, in these Ras-
transformed cells, autophagy induction by farnesylthiosalicylic acid was also associated with 
inhibition of tumour growth (273). The differential effect could be linked to Ras transformation 
as opposed to myc transformation. A recent report indicates that myc-dependent excess cell 
growth requires autophagy (274). This study performed in Drosophila melanogaster identifies 
myc as being a physiological regulator of autophagy. Under starvation condition, myc was 
required for the formation of acidic, ATG8-positive puncta, and loss of myc inhibited autophagy. 
From a mechanistic view, myc overexpression resulted in an increase in the unfolded protein 
response due to an accumulation of ubiquitinated proteins, which led to phosphorylation of 
eIF2α by pancreatic eIF2α kinase (PERK) leading to autophagy induction, a process antagonized 
by GADD-34 (274). Similarly, myc has been reported to be responsible for the metabolic 
reprogramming required to ensure lymphocyte clonal expansion after activation, a process which 
is glutamine dependent (275). When combined, these data would suggest that myc 
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transformation is both capable of reprogramming cells for rapid proliferation but rendering them 
glutamine-dependent, and to induce autophagy in order to provide building blocks and 
adaptation capacity. 
These reports all support the findings of this study. In addition to the findings that 
autophagy is a crucial process in Sp2/0 cells is the finding that the levels of available glutamine 
are capable of modulating autophagy. In Sp2/0 cells cultured at or above the threshold glutamine 
concentration of 100 µM where cells are viable, the acidic compartments are brightly stained, 
whereas below this threshold, the intensity of the signal is markedly decreased (figures 3.23, 
3.24). From a temporal perspective, the intensity of the acidic compartment staining is 
significantly decreased as early as 4h after transfer into a medium containing limiting amounts of 
glutamine (figures 3.26 and 3.27). The ability of glutamine to affect autophagy has been 
previously reported (276-279). The inhibition of autophagy by ATG5 siRNA or by chloroquine 
or assaying protein half-life with 35S-labelled methionine could be performed to further confirm 
the ability of glutamine to affect autophagy in these temporal and glutamine-limiting conditions.  
A sufficient amount of glutamine is required for Sp2/0 cell survival. However, its 
importance is not strictly related to the ability of glutamine to provide fuel to the TCA cycle. 
This is evidenced by the fact that cells cultured in glutamine-limiting conditions which typically 
led to reduced viability at 24h were capable of proliferation as long as a source of ammonium 
ions was supplied (figure 3.40). The by-product of glutamine metabolism, ammonium ion, has 
been shown to induce autophagy (231). There is an interesting difference in Sp2/0 cell viability 
and density when autophagy was stimulated by rapamycin or ammonium ions. In figure 3.36, 
autophagy was stimulated by rapamycin in Sp2/0 cells maintained under glutamine-limiting 
conditions. Cells had increased survival when compared to the solvent-treated, but cell density 
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did not increase, a result consistent with mTOR inhibition (280). In figure 3.40, cells cultured 
under glutamine-limiting conditions were treated with ammonium ions to stimulate autophagy. It 
should be noted that ammonium ions may have influenced other cellular processes that could 
also contribute to cell viability. In those conditions, cell viability was partially restored and cell 
density increased to levels observed in glutamine-rich conditions (see figure 3.1). The 
stimulation of autophagy can therefore be either mTOR-dependent or mTOR-independent, 
rapamycin stimulating autophagy by inhibition of mTOR while ammonium ions have been 
shown to induce autophagy in a mTOR-independent manner (92). It is possible that combining 
rapamycin and ammonium ion treatments could lead to a synergistic effect on Sp2/0 cell viability 
when cells are cultured in 25 µM glutamine, potentially rescuing viability to a level as that seen 
in glutamine-rich conditions. However since rapamycin also inhibits cell proliferation, the 
synergistic effect may be offset by a lower rate of proliferation.    
Sp2/0 cells cultured under glutamine-limiting conditions did not increase the cell density 
over 24h, but rather underwent apoptosis, leaving approximately 30% of viable cells (figure 3.1). 
Additionally, Sp2/0 cells cultured in glutamine-rich conditions but in the presence of rapamycin, 
an mTOR-dependent stimulator of autophagy, cell density was significantly decreased while 
viability was maintained (see figure 3.37) while rescuing viability but not proliferation in 
glutamine-limited conditions (see figure 3.38). But when Sp2/0 cells were cultured for 24h in 
glutamine-limiting conditions in the presence of ammonium ions, viability was increased as was 
cell density. The ability of ammonium to restore proliferative capacity to Sp2/0 cells in 
glutamine-limiting conditions could be verified by cell cycle distribution analysis by flow 
cytometry, using rapamycin as a contrasting autophagic stimulation shown to prevent 
proliferation in this model. Interestingly, in a recent report, plumbagin, an agent with 
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anticarcinogenic, antiatherosclerotic and antimicrobial properties, prevents cell proliferation and 
triggered autophagic cell death by inhibiting the mTOR/Akt pathway, inducing a G2/M arrest 
with a concomitant reduction in cyclin B1, cyclin A and cyclin-dependent kinase 1 (Cdk1) (281). 
In Sp2/0 cells cultured in 25 µM glutamine, there was a decrease in the percentage of cells in 
G2/M with a corresponding increase in sub-G1 cell percentage. Examination of cyclin A, cyclin 
B1 and Cdk1 when cells are cultured in 25 µM glutamine with ammonium salt treatments may 
provide further evidence to the ability of ammonium salts to restore proliferative capacity, even 
in glutamine-limiting conditions.  
When considering the cell cycle, the threshold concentration of 100 µM glutamine must 
be considered. At this concentration, Sp2/0 cells were viable but not proliferating and were 
arrested in the G1 phase (figure 3.2). Arrest in the G1 phase has been induced by downregulation 
of cyclin D1 in mTOR inhibition by temsirolimus. The ability of temsirolimus to prevent 
proliferation was augmented by the addition of chloroquine, an autophagy inhibitor (282). In 
another report, piperine treatment also lead to G1 cell cycle arrest, downregulation of cyclin D1 
and cyclinA, but promoted autophagy induction without inducing apoptosis (283). Examination 
of cyclin D1 temporally in glutamine limitation with ammonium treatment may also yield 
interesting information.  
It can be postulated that an increase in the rate of autophagy caused by the ammonium 
salt treatment is the mechanism for the rescue of cell viability and function in glutamine 
restriction. Unbiased quantitative measure of autophagic flux has been difficult. Most methods 
require the counting of autophagic vacuoles by microscopy but recently, several flow cytometry-
based methods have been described. A new method was recently described using flow 
cytometry, sonication to release cellular substructures and acridine orange staining (255). The 
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technique takes advantage of the sensitivity of flow cytometry and the differential staining of 
acridine orange when excited. Acridine orange emits in the green spectrum when bound to DNA 
and in the red-orange spectrum when in acidic vacuoles. A high red, low green signal would be 
indicative of an acidic vacuole (255). Another method would involve LC3-GFP transfection of 
cells co-stained with monodansylcadeverin, an autofluorescent dye that accumulates in lipid 
membranes of autophagic vacuoles much like acridine orange, and subjected to flow cytometry. 
Such staining has been reported to be used to measure autophagic flux (119, 284). In another 
method reported in Drosophila transfected with a UASp-GFP-mCherry-DrAtg8a transgene 
(285). Once expressed, Atg8, the LC3B homologue, was dual-tagged. When autophagy was not 
occurring, Atg8 was diffuse in the cytoplasm and fluoresced in the yellow spectrum because of 
an overlap between the green (GFP) and red (mCherry) signals. When autophagy was triggered 
and Atg8 was lipidated, the yellow signal would migrate to autophagosomes and form puncta. 
When the autophagosome fused with lysosomes, hydrolases quenched the GFP signal and only 
the mCherry signal was detected (285).  These investigations could provide interesting results 
when considering that Sp2/0 cells proliferate at a high rate.  
4.2 — Overall Conclusions and Significance 
Overall, this body of work shows that glutamine can affect cell behaviour and influence 
cell signalling to effect cell survival. Moreover, the results suggest that autophagy is a critical 
mechanism in Sp2/0 cells that allows cells to proliferate even in glutamine-limiting conditions. 
Autophagy would allow this to occur by recycling non-essential organelles or macromolecules 
into the building blocks needed for cell replication. What would be required is the signal to do 
so. As evidenced by this work, this signal could very well be provided by glutamine.  
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This body of work allows for the conclusion that ammonium ions, likely originating from 
glutaminolysis, allow the Sp2/0 cells to not only survive in the presence of stress due to nutrient 
deprivation and protects cells from apoptosis, but also allows for proliferation in times of 
nutrient restriction. The ability to resist apoptosis, survive in nutrient-restricted conditions and 
even proliferate could be made possible, at least in part, by the successful induction of the 
autophagic pathway. As the Sp2/0 cell line is used to commercially manufacture monoclonal 
antibodies, the discovery that autophagy stimulation via ammonium could allow the Sp2/0 cells 
to adapt to nutrient-limiting conditions while maintaining the ability to sustain proliferation is a 
practical way to ensure antibody production without the need for expensive additives to culture 
media.  
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Appendix A — Supplementary Figures 
 
A.1 - Mitotracker Red At 4h 
Confocal microscopy picture of cells at 63X magnification, cultured for 4h the 
indicated concentration of glutamine and stained with Mitotracker H2ROS Red. 
Representative of 3 independent experiments (figure 3.16), with at least 5 fields 
for each sample.  
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Cell Cycle Stage 0h 4h 8h 24h 24h + Q 
Sub G0 0.81 3.46* 5.19* 21.36* ¶ ŧ 3.16 
G0/G1 29.28 32.86 34.74¶ 32.05 42.31* ¶ 
S 26.36 32.00 26.58¶ 20.17* ¶ ŧ 17.96¶ 
G2/M 24.43 22.24 25.19 10.83* ¶ ŧ 19.19* 
A.2 - Percentage Distribution in the Cell Cycle 
Sp2/0 cells were cultured in 25 µM glutamine over 24h for the indicated length of 
time before collection and subsequent EtOH fixation. Cellular DNA content was 
stained with propidium iodide and analysed by flow cytometry. Data represents 
the mean of 3 independent experiments and is presented in figure 3.19. Statistical 
significance assessed by paired t-test with * p<0.05 compared to 0h, ¶ p<0.05 
compared to 4h and ŧ p<0.05 compared to 8h.  
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Sample Band 1000 µM Q 250 µM Q 100 µM Q 50 µM Q 25 µM Q 
1 
LC3-II 1.42 0.58 0.4 0.35 1 
LC3-I 1.35 0.62 0.39 0.22 1 
2 
LC3-II 2.07 1.67 0.80 0.80 1 
LC3-I 2.54 1.43 0.62 0.36 1 
3 
LC3-II 1.10 0.86 0.85 0.68 1 
LC3-I 1.11 2.03 1.31 0.19 1 
A.3 - β-actin-Normalized Densitometry Expressed Relative to 25 µM 
Treatment Group in the Gradual Limitation Model 
Densitometry values for the LC3-II and LC3-I bands as obtained by Western 
blotting and presented in figure 3.31. The densitometry readings were normalized 




Sample Ratio 1000 µM Q 250 µM Q 100 µM Q 50 µM Q 25 µM Q 
1 LC3-II / 
LC3-I 2.9 2.6 2.8 4.4 2.8 
2 LC3-II / 
LC3-I 1.6 2.3 2.5 4.4 1.9 
3 LC3-II / 
LC3-I 17.8 7.6 11.7 64.1 18.0 
A.4 - β-actin-Normalized Densitometry of LC3-II:LC3-1 Within Each 
Treatment Group in the Gradual Limitation Model 
Ratio of LC3-II:LC3-I values calculated from the densitometry data presented in 
A.3. The ratios present the relative densitometry readings of LC3-II when 
compared to the LC3-I for each condition.  
!  
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Sample T=0h T=4h T=8h T=24h T=24h + Q 
1 1 0.72 0.68 1.58 2.43 
2 1 0.93 0.96 1.66 1.42 
3 1 0.96 0.74 1.20 1.28 
A.5 - β-actin-Normalized Densitometry Expressed Relative to Baseline Group 
in the Time Course Model 
Densitometry values for the LC3-II band as obtained by Western blotting and 
presented in figure 3.31. The densitometry readings for the LC3-II band were 
normalized to the densitometry reading of β-actin then compared to the baseline 
(t=0h) treatment group. 
!  
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Sample 25 µMQ AA ACl NaA NaCl 
1 1 2.04 1.51 0.6 1.07 
2 1 16.85 28.51 7.27 8.90 
3 1 5.20 6.45 3.65 2.93 
A.6 - β-actin-Normalized Densitometry Expressed Relative to 25 µM 
Treatment Group in the Ammonium Model 
Densitometry values for the LC3-II band as obtained by Western blotting and 
presented in figure 3.49. The densitometry readings for the LC3-II band were 
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